<SUBMISSION>
<ACCESSION-NUMBER>0000950134-06-007770
<TYPE>DEF 14A
<PUBLIC-DOCUMENT-COUNT>5
<PERIOD>20060606
<FILING-DATE>20060424
<DATE-OF-FILING-DATE-CHANGE>20060424
<EFFECTIVENESS-DATE>20060424
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ADEZA BIOMEDICAL CORP
<CIK>0000902482
<ASSIGNED-SIC>3825
<IRS-NUMBER>770054952
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>DEF 14A
<ACT>34
<FILE-NUMBER>000-20703
<FILM-NUMBER>06775935
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1240 ELKO DR
<CITY>SUNNYVALE
<STATE>CA
<ZIP>94089
</BUSINESS-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>f19772dedef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>def14a</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>





<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 13pt"><B>Washington, D.C. 20549</B></DIV>


<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>SCHEDULE 14A</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the Securities<BR>
Exchange Act of 1934</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Filed by the Registrant <FONT face="Wingdings">&#254;</FONT>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Filed by a Party other than the Registrant <FONT face="Wingdings">&#111;</FONT>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Check the appropriate box:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Preliminary Proxy Statement

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> <B>Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#254;</FONT> Definitive Proxy Statement

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Definitive Additional Materials

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Soliciting Material Pursuant to &#167;240.14a-12

</DIV>
<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>Adeza Biomedical Corporation</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&nbsp;
</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
(Name of Registrant as Specified In Its Charter)</DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&nbsp;
</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<DIV align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of Filing Fee (Check the appropriate box):</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#254;</FONT> No fee required.

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Fee computed on table below per Exchange Act Rules&nbsp;14a-6(i)(4) and 0-11.

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1) Title of each class of securities to which transaction applies:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2) Aggregate number of securities to which transaction applies:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule&nbsp;0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4) Proposed maximum aggregate value of transaction:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5) Total fee paid:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT> Fee paid previously with preliminary materials.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT> Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the Form or Schedule and the date of its filing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1) Amount Previously Paid:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2) Form, Schedule or Registration Statement No.:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3) Filing Party:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4) Date Filed:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<P align="center" style="font-size: 10pt">
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 14pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">ADEZA
    BIOMEDICAL CORPORATION</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">Notice of Annual Meeting of
    Stockholders</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">To Be Held June&#160;6,
    2006</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Annual Meeting of Stockholders of Adeza Biomedical
    Corporation (the &#147;Company&#148;) will be held on
    June&#160;6, 2006 at 11:00&#160;a.m. local time, at the offices
    of Heller Ehrman LLP, the Company&#146;s legal counsel, located
    at 275 Middlefield Road, Menlo Park, California, 94025, for the
    following purposes, as more fully described in the accompanying
    Proxy Statement:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    1.&#160;To elect two Class&#160;II directors to hold office
    until the 2009 Annual Meeting of Stockholders and until their
    successors are elected and qualified.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    2.&#160;To ratify the appointment of Ernst&#160;&#38; Young LLP
    as the Company&#146;s independent registered public accounting
    firm for the fiscal year ending December&#160;31, 2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    3.&#160;To transact such other business as may properly come
    before the meeting or any adjournments or postponements thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Only stockholders of record at the close of business on
    April&#160;17, 2006 will be entitled to notice of, and to vote
    at, such meeting or any adjournments or postponements thereof.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    By Order of the Board of Directors
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <IMG src="f19772def1977201.gif" alt="-s- Emory V. Anderson" >
</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Emory V. Anderson
</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    President, Chief Executive Officer and Secretary
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Sunnyvale, California
</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    April&#160;28, 2006
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">YOUR VOTE
    IS IMPORTANT!</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE
    COMPLETE, SIGN, DATE AND MAIL PROMPTLY THE ACCOMPANYING PROXY
    CARD IN THE ENCLOSED RETURN ENVELOPE, WHICH REQUIRES NO POSTAGE
    IF MAILED IN THE UNITED STATES. THIS WILL ENSURE THE PRESENCE OF
    A QUORUM AT THE MEETING. IF YOU ATTEND THE MEETING, YOU MAY VOTE
    IN PERSON IF YOU WISH TO DO SO EVEN IF YOU HAVE PREVIOUSLY SENT
    IN YOUR PROXY CARD.</B>
</DIV>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 14pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Adeza
    Biomedical Corporation<BR>
    <FONT style="font-size: 10pt">1240 Elko Drive<BR>
    Sunnyvale, California 94089<BR>
    <FONT style="white-space: nowrap">(408)&#160;745-0975</FONT></FONT></FONT></B>
</DIV>


<!-- link1 "PROXY STATEMENT" -->


<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 12pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">PROXY
    STATEMENT</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">2006 ANNUAL MEETING OF
    STOCKHOLDERS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Adeza Biomedical Corporation (the &#147;Company&#148;) is
    furnishing this Proxy Statement and the enclosed proxy in
    connection with the solicitation of proxies by the Board of
    Directors of the Company (the &#147;Board&#148;) for use at the
    Annual Meeting of Stockholders to be held on June&#160;6, 2006,
    at 11:00&#160;a.m. local time, at offices of Heller Ehrman LLP,
    the Company&#146;s legal counsel, located at 275 Middlefield
    Road, Menlo Park, California
    <FONT style="white-space: nowrap">94025-3506,</FONT>
    and at any adjournments thereof (the &#147;Annual
    Meeting&#148;). These materials are being mailed to stockholders
    on or about April&#160;28, 2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Only holders of the Company&#146;s common stock as of the close
    of business on April&#160;17, 2006 (the &#147;Record Date&#148;)
    are entitled to vote at the Annual Meeting. Stockholders who
    hold shares of the Company in &#147;street name&#148; may vote
    at the Annual Meeting only if they hold a valid proxy from their
    broker. As of the Record Date, there were 17,449,420&#160;shares
    of common stock outstanding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    A majority of the outstanding shares of common stock entitled to
    vote at the Annual Meeting must be present in person or by proxy
    in order for there to be a quorum at the meeting. Stockholders
    of record who are present at the meeting in person or by proxy
    and who abstain from voting, including brokers holding
    customers&#146; shares of record who cause abstentions to be
    recorded at the meeting, will be included in the number of
    stockholders present at the meeting for purposes of determining
    whether a quorum is present.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each stockholder of record is entitled to one vote at the Annual
    Meeting for each share of common stock held by such stockholder
    on the Record Date. Stockholders do not have cumulative voting
    rights. Stockholders may vote their shares by using the proxy
    card enclosed with this Proxy Statement. All proxy cards
    received by the Company which are properly signed and have not
    been revoked will be voted in accordance with the instructions
    contained in the proxy cards. If a signed proxy card is received
    which does not specify a vote or an abstention, the shares
    represented by that proxy card will be voted for the nominees to
    the Board listed on the proxy card and in this Proxy Statement
    and for the ratification of the appointment of Ernst&#160;&#38;
    Young LLP as the Company&#146;s independent registered public
    accounting firm for the year ending December&#160;31, 2006. The
    Company is not aware, as of the date hereof, of any matters to
    be voted upon at the Annual Meeting other than those stated in
    this Proxy Statement and the accompanying Notice of Annual
    Meeting of Stockholders. If any other matters are properly
    brought before the Annual Meeting, the enclosed proxy card gives
    discretionary authority to the persons named as proxies to vote
    the shares represented by the proxy card in their discretion.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under Delaware law and the Company&#146;s Amended and Restated
    Certificate of Incorporation and Bylaws, if a quorum exists at
    the meeting, the affirmative vote of a plurality of the votes
    cast at the meeting is required for the election of directors. A
    properly executed proxy marked &#147;Withhold authority&#148;
    with respect to the election of one or more directors will not
    be voted with respect to the director or directors indicated,
    although it will be counted for purposes of determining whether
    there is a quorum. For each other item, the affirmative vote of
    the holders of a majority of the shares represented in person or
    by proxy and entitled to vote on the item will be required for
    approval. A properly executed proxy marked &#147;Abstain&#148;
    with respect to any such matter will not be voted, although it
    will be counted for purposes of determining whether there is a
    quorum. Accordingly, an abstention will have the effect of a
    negative vote.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For shares held in &#147;street name&#148; through a broker or
    other nominee, the broker or nominee may not be permitted to
    exercise voting discretion with respect to some of the matters
    to be acted upon. Thus, if stockholders do not give their broker
    or nominee specific instructions, their shares may not be voted
    on those matters and will not be counted in determining the
    number of shares necessary for approval. Shares represented by
    such &#147;broker non-votes&#148; will, however, be counted in
    determining whether there is a quorum.
</DIV>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    A stockholder of record may revoke a proxy at any time before it
    is voted at the Annual Meeting by (a)&#160;delivering a proxy
    revocation or another duly executed proxy bearing a later date
    to the Secretary of the Company at 1240 Elko Drive, Sunnyvale,
    California 94089 (attention: Secretary) or (b)&#160;attending
    the Annual Meeting and voting in person. Attendance at the
    Annual Meeting will not revoke a proxy unless the stockholder
    actually votes in person at the meeting.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The proxy card accompanying this Proxy Statement is solicited by
    the Board of the Company. The Company will pay all of the costs
    of soliciting proxies. In addition to solicitation by mail,
    officers, directors and employees of the Company may solicit
    proxies personally, or by telephone, without receiving
    additional compensation. In addition, the Company may retain a
    proxy solicitation firm to assist in the solicitation of proxies
    in connection with the Annual Meeting. If the Company engages a
    proxy solicitation firm, the Company will pay such firm&#146;s
    customary fees, which the Company expects would be approximately
    $10,000 plus expenses. The Company, if requested, will also pay
    brokers, banks and other fiduciaries who hold shares of Common
    Stock for beneficial owners for their reasonable
    <FONT style="white-space: nowrap">out-of-pocket</FONT>
    expenses of forwarding these materials to stockholders.
</DIV>


<!-- link1 "BOARD OF DIRECTORS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">BOARD OF
    DIRECTORS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The name, age, position with the Company and year in which the
    term expires of each member of the Board of the Company is set
    forth below:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="43%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=quadleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=quadright -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="35%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="6%">&nbsp;</TD>	<!-- colindex=04 type=quadleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
    <TD width="6%">&nbsp;</TD>	<!-- colindex=04 type=quadright -->
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Term Expires<BR>
    </FONT></B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">on the<BR>
    </FONT></B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Annual Meeting<BR>
    </FONT></B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">Name</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">Age</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">Position(s) with the
    Company</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">held in the Year</FONT></B>
</DIV>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Andrew E. Senyei, MD(2)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">56
    </FONT>
</TD>
<TD>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="bottom">
    <FONT style="font-size: 10pt">Chairman of the Board
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">2006
    </FONT>
</TD>
<TD>
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Emory V. Anderson
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">51
    </FONT>
</TD>
<TD>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="bottom">
    <FONT style="font-size: 10pt">President, Chief Executive Officer
    and Director
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">2007
    </FONT>
</TD>
<TD>
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Nancy D. Burrus(1)(2)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">51
    </FONT>
</TD>
<TD>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    <FONT style="font-size: 10pt">Director
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">2008
    </FONT>
</TD>
<TD>
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Michael P. Downey(1)(2)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">58
    </FONT>
</TD>
<TD>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    <FONT style="font-size: 10pt">Director
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">2006
    </FONT>
</TD>
<TD>
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Craig C. Taylor(1)(3)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">55
    </FONT>
</TD>
<TD>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    <FONT style="font-size: 10pt">Director
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">2008
    </FONT>
</TD>
<TD>
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Kathleen D. LaPorte(3)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">44
    </FONT>
</TD>
<TD>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    <FONT style="font-size: 10pt">Director
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">2007
    </FONT>
</TD>
<TD>
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">C. Gregory Vontz
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">45
    </FONT>
</TD>
<TD>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    <FONT style="font-size: 10pt">Director
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD>
</TD>
<TD nowrap align="right" valign="top">
    <FONT style="font-size: 10pt">2008
    </FONT>
</TD>
<TD>
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%; align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    (1) </TD>
    <TD></TD>
    <TD valign="bottom">
    Member of audit committee</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR>
    <TD align="right" valign="top">
    (2) </TD>
    <TD></TD>
    <TD valign="bottom">
    Member of compensation committee</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR>
    <TD align="right" valign="top">
    (3) </TD>
    <TD></TD>
    <TD valign="bottom">
    Member of nominating and corporate governance committee</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At the Annual Meeting, the stockholders will vote on the
    election of Andrew E. Senyei, MD and Michael P. Downey as
    Class&#160;II directors to serve for a three-year term until the
    annual meeting of stockholders in 2009 and until their
    successors are elected and qualified. All directors will hold
    office until the annual meeting of stockholders at which their
    terms expire and the election and qualification of their
    successors.
</DIV>


<!-- link1 "NOMINEES AND CONTINUING DIRECTORS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">NOMINEES
    AND CONTINUING DIRECTORS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following individuals have been nominated for election to
    the Board or will continue to serve on the Board after the
    Annual Meeting:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Andrew E. Senyei, MD, Chairman of the Board</I>, has served
    as one of our directors since 1987. Dr.&#160;Senyei has been a
    Managing Director and a General Partner of Enterprise Partners,
    a venture capital firm, since 1987. Dr.&#160;Senyei was a
    founder of Molecular Biosystems and, prior to joining Enterprise
    Partners, was a practicing clinician and Adjunct Associate
    Professor of Obstetrics, Gynecology and Pediatrics at the
    University of California at Irvine. He serves on the boards of
    directors of numerous private healthcare companies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Emory V. Anderson </I>has been our President and Chief
    Executive Officer since February 1997. From October 1992 to
    February 1997, Mr.&#160;Anderson was our Vice President and
    Chief Financial Officer. Prior to joining us,
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    2
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Mr.&#160;Anderson served as Executive Vice President and Chief
    Operating Officer of Indesys, Inc., which he co-founded in 1984.
    Previously, he held the position of Director of Finance for
    Atari, Inc.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Nancy D. Burrus </I>has served as one of our directors since
    December of 1994. Ms.&#160;Burrus has been a general partner of
    IndoSuez Ventures, a venture capital firm, since 1990. IndoSuez
    Ventures manages STF&#160;II, L.P., one of our institutional
    shareholders. Prior to joining Suez Ventures, Ms.&#160;Burrus
    was a Vice President with Morgan Stanley Ventures. She serves on
    the boards of directors of several private companies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Michael P. Downey </I>has served as one of our directors
    since March 2005. Mr.&#160;Downey has served in various
    executive positions at Nellcor Puritan Bennett and one of its
    predecessors, most recently as executive vice president and
    chief financial officer. He has also held several executive
    positions at Shugart Corporation, including Vice President of
    Finance. Prior to that, Mr.&#160;Downey held several financial
    management positions with General Motors Corporation. He
    currently serves on the board of directors of Vertical
    Communications, Inc. (formerly Artisoft, Inc.), Emulex
    Corporation and First Consulting Group, Inc.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Kathleen D. LaPorte </I>has served as one of our directors
    since April of 2002. Ms.&#160;LaPorte is a Managing Director of
    New Leaf Venture Partners, LLC, a venture capital firm.
    Ms.&#160;LaPorte served as a general partner of Sprout Group, a
    venture capital firm, from 1994 until 2005. Prior to joining the
    Sprout Group, Ms.&#160;LaPorte was a principal at Asset
    Management Company, a venture capital firm focused on early
    stage investments. She has also worked as a financial analyst
    with The First Boston Corporation. She serves on the board of
    directors of VNUS Medical Technologies, Inc. and ISTA
    Pharmaceuticals, Inc., both publicly held companies, and several
    private companies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Craig C. Taylor </I>has served as one of our directors since
    1986. Mr.&#160;Taylor heads the life science investments at
    Alloy Ventures and has been active in venture capital since
    1977. He serves on the board of directors of Pharmacyclics and
    Solexa, both publicly held companies, and several private
    companies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>C.&#160;Gregory Vontz </I>has served as one of our directors
    since February 2006. Mr.&#160;Vontz has served as the Chief
    Operating Officer of Connetics Corporation, a specialty
    pharmaceutical company, since January 2001, and as the President
    of Connetics since February 2005. Before joining Connetics,
    Mr.&#160;Vontz served 12&#160;years with Genentech, Inc., most
    recently as Director of New Markets and Healthcare Policy.
    Before joining Genentech, Inc. in 1987, Mr.&#160;Vontz worked
    for Merck&#160;&#38; Co., Inc.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    There are no family relationships among any of the
    Company&#146;s directors or executive officers.
</DIV>


<!-- link1 "DIRECTOR NOMINATION" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">DIRECTOR
    NOMINATION</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The information below describes the criteria and process that
    the nominating and corporate governance committee uses to
    evaluate candidates to the Board.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Board Membership Criteria.</I>&#160;&#160;The nominating and
    corporate governance committee is responsible for assessing the
    appropriate balance of experience, skills and characteristics
    required of the Board. Nominees for director are selected on the
    basis of depth and breadth of experience, knowledge, integrity,
    ability to make independent analytical inquiries, understanding
    of the Company&#146;s business environment, the willingness to
    devote adequate time to Board duties, the interplay of the
    candidate&#146;s experience and skills with those of other Board
    members, and the extent to which the candidate would be a
    desirable addition to the Board and any committees of the Board.
    Additionally, the nominating and corporate governance committee
    seeks to ensure that at least a majority of the directors are
    independent under the rules of the Nasdaq Stock Market, that the
    audit committee and compensation committee are composed entirely
    of independent directors, and that members of the audit
    committee possess such accounting and financial expertise as the
    principal stock exchange or quotation service on which the
    Company&#146;s shares are listed or quoted shall require.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Stockholder Proposals for Nominees.</I>&#160;&#160;The
    nominating and corporate governance committee will consider
    written proposals from stockholders for director nominees. Any
    such nominations should be submitted to the nominating and
    corporate governance committee c/o&#160;the Secretary of the
    Company and should include (at a minimum) the following
    information: (a)&#160;all information relating to such nominee
    that is required to be disclosed pursuant to Regulation&#160;14A
    under the Securities Exchange Act of 1934 (including such
    person&#146;s written consent to
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    3
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    being named in the proxy statement as a nominee and to serving
    as a director if elected); (b)&#160;the name(s) and address(es)
    of the stockholder(s) making the nomination and the number of
    shares of the Company&#146;s common stock which are owned
    beneficially and of record by such stockholder(s); and
    (c)&#160;appropriate biographical information and a statement as
    to the qualifications of the nominee, and should be submitted in
    the time frame described in the Bylaws of the Company and under
    the caption, &#147;<I>Stockholder Proposals</I>&#148; below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Process for Identifying and Evaluating
    Nominees.</I>&#160;&#160;The nominating and corporate governance
    committee initiates the process for identifying and evaluating
    nominees to the Board by identifying a slate of candidates who
    meet the criteria for selection as nominees and have the
    specific qualities or skills being sought based on input from
    members of the Board, management and, if the nominating and
    corporate governance committee deems appropriate, a third-party
    search firm. Candidates are evaluated by the nominating and
    corporate governance committee on the basis of the factors
    described above under &#147;<I>Board Membership
    Criteria</I>&#148;.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    With respect to candidates for initial election to the Board,
    the nominating and corporate governance committee also reviews
    biographical information and qualifications and checks the
    candidates&#146; references. Qualified candidates are
    interviewed by at least one member of the nominating and
    corporate governance committee. Serious candidates meet, either
    in person or by telephone, with all members of the nominating
    and corporate governance committee and as many other members of
    the Board as practicable.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Using the input from interviews and the information obtained by
    the nominating and corporate governance committee, the
    nominating and corporate governance committee evaluates which of
    the prospective candidates is qualified to serve as a director
    and whether the committee should recommend to the independent
    members of the Board that the Board nominate, or elect to fill a
    vacancy, with a final prospective candidate. Candidates
    recommended by the nominating and corporate governance committee
    are presented to the independent members of the Board for
    selection as nominees to be presented for the approval of the
    stockholders or for election to fill a vacancy. The nominating
    and corporate governance committee expects that a similar
    process will be used to evaluate nominees recommended by
    stockholders. However, to date, the Company has not received any
    stockholder proposal to nominate a director.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Nominees to the Board of Directors for the Annual
    Meeting.</I>&#160;&#160;The nominees for the Annual Meeting are
    current directors and were recommended for selection by the
    nominating and corporate governance committee and were selected
    by the independent members of the Board.
</DIV>


<!-- link1 "DIRECTOR COMPENSATION" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">DIRECTOR
    COMPENSATION</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the Company&#146;s non-employee director
    compensation policy: (i)&#160;the chairman of the Board receives
    a quarterly retainer of $10,000; (ii)&#160;the chair of each of
    the standing committees of the Board (other than the chairman of
    the Board) receives a quarterly retainer of $9,000; and
    (iii)&#160;each other non-employee director receives a quarterly
    retainer of $8,000. The quarterly retainers provided for in the
    policy are intended to cover up to 15 in person board and
    committee meetings annually. Directors receive an additional
    $1,000 per in person board or committee meeting in excess of 15
    meetings. In addition, directors are reimbursed for certain
    expenses in connection with attending Board and committee
    meetings. Mr.&#160;Anderson does not receive additional
    compensation for his service as a director.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Non-employee directors also receive automatic grants of options
    to purchase shares Common Stock pursuant to the Company&#146;s
    2004 Equity Incentive Plan (the &#147;2004 Plan&#148;). The 2004
    Plan provides for the annual grant of an option to purchase
    11,250&#160;shares of Common Stock to the chairman of the Board
    and 7,500&#160;shares to each other non-employee director. The
    annual option grants are made on the date of the Company&#146;s
    annual meeting to non-employee directors with at least six
    months of Board service and vest in 12 equal monthly
    installments. Newly elected non-employee directors receive an
    option to purchase 22,500&#160;shares of Common Stock
    (30,000&#160;shares in the case of newly elected director who is
    appointed chairman of the Board) vesting in 48 equal monthly
    installments. The exercise price of the options granted to
    non-employee directors is equal to the fair market value of the
    Common Stock, as determined under the 2004 Plan.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    4
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "BOARD MEETINGS AND COMMITTEES" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">BOARD
    MEETINGS AND COMMITTEES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Board met 6 times during 2005. The audit committee met 7
    times, the compensation committee met 5 times, and the
    nominating and corporate governance committee met 3 times during
    fiscal 2005. Each member of the Board attended 75% or more of
    the Board meetings, and each member of the Board who served on
    either the audit, compensation or nominating committee attended
    at least 75% of the committee meetings.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Board has determined that the following directors are
    &#147;independent&#148; under current Nasdaq rules: Andrew E.
    Senyei, Nancy D. Burrus, Michael P. Downey, Kathleen D. LaPorte,
    Craig C. Taylor and C. Greogry Vontz.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Board has standing audit, compensation and nominating and
    corporate governance committees.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Audit Committee.</I>&#160;&#160;The audit committee currently
    consists of Michael P. Downey (chair), Nancy D. Burrus and Craig
    C. Taylor. The Board has determined that all members of the
    audit committee are independent directors under the rules of the
    Nasdaq Stock Market and each of them is able to read and
    understand fundamental financial statements. The Board has
    determined that Mr.&#160;Downey qualifies as an &#147;audit
    committee financial expert&#148; as defined by the rules of the
    Securities and Exchange Commission. The purpose of the audit
    committee is to oversee the accounting and financial reporting
    processes of the Company and audits and reviews of its financial
    statements. The responsibilities of the audit committee include
    appointing and providing for the compensation of the
    Company&#146;s independent registered public accounting firm to
    conduct the annual audit and quarterly reviews of the
    Company&#146;s financial statements, reviewing the scope and
    results of the independent audits, reviewing and evaluating
    internal accounting policies, and approving all professional
    services to be provided to the Company by its independent
    registered public accounting firm.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Compensation Committee.</I>&#160;&#160;The compensation
    committee currently consists of Andrew E. Senyei (chair), Nancy
    D. Burrus and Michael P. Downey. The Board has determined that
    all members of the compensation committee are independent
    directors under the rules of the Nasdaq Stock Market. The
    compensation committee administers the Company&#146;s benefit
    plans, reviews and administers all compensation arrangements for
    executive officers, and establishes and reviews general policies
    relating to the compensation and benefits of our officers and
    employees.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Nominating and Corporate Governance
    Committee.</I>&#160;&#160;The nominating and corporate
    governance committee consists of Ms.&#160;LaPorte (chair) and
    Mr.&#160;Taylor. The nominating and corporate governance
    committee is responsible for identifying individuals qualified
    to serve as members of the Board of the Company, recommending to
    the independent members of the Board nominees for election as
    directors of the Company and providing oversight with respect to
    corporate governance and ethical conduct. The Company believes
    that the functioning of its nominating and corporate governance
    committee complies with applicable requirements of the Nasdaq
    National Market and SEC rules and regulations. A copy of the
    charter of the nominating and corporate governance committee can
    be found at: <I>http://www.adeza.com.</I>
</DIV>


<!-- link1 "COMMUNICATIONS WITH DIRECTORS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">COMMUNICATIONS
    WITH DIRECTORS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Stockholders or other interested parties may communicate with
    any director or committee of the Board by writing to them
    c/o&#160;Chief Financial Officer, 1240 Elko Drive, Sunnyvale,
    California 94089. Comments or questions regarding the
    Company&#146;s accounting, internal controls or auditing matters
    will be referred to members of the audit committee. Comments or
    questions regarding the nomination of directors and other
    corporate governance matters will be referred to members of the
    nominating and corporate governance committee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company currently has a policy of encouraging all directors
    to attend the annual stockholder meetings. The Company held an
    annual stockholder meeting on June&#160;9, 2005. All of the
    Company&#146;s directors attended the 2005 annual meeting.
</DIV>


<!-- link1 "COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">COMPENSATION
    COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    No interlocking relationship exists, or in the past fiscal year
    has existed, between any member of our compensation committee
    and any member of any other company&#146;s board of directors or
    compensation committee.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    5
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "CODE OF ETHICS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">CODE OF
    ETHICS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company has adopted a code of ethics, containing general
    guidelines for conducting our business consistent with high
    standards of business ethics. The code of ethics is designed to
    qualify as a &#147;code of ethics&#148; within the meaning of
    Section&#160;406 of the Sarbanes-Oxley Act of 2002 and the rules
    promulgated there under as well as under applicable rules of The
    Nasdaq National Market. Our code of ethics is available on the
    Investor Relations section of our website (www.adeza.com), which
    is under the Corporate section of our website. To the extent
    permitted by regulatory requirements, we intend to make such
    public disclosure by posting the relevant material on the
    Investor Relations section of our website in accordance with SEC
    rules.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    6
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "SECURITY OWNERSHIP BY CERTAIN BENEFICIAL HOLDERS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SECURITY
    OWNERSHIP BY CERTAIN BENEFICIAL HOLDERS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table sets forth information regarding ownership
    of the Common Stock as of March&#160;31, 2006 or earlier date
    for information based on filings with the Securities and
    Exchange Commission by (a)&#160;each person known to the Company
    to own more than 5% of the outstanding shares of the Common
    Stock, (b)&#160;each director and nominee for director of the
    Company, (c)&#160;the Company&#146;s Chief Executive Officer and
    each other executive officer named in the compensation tables
    appearing later in this Proxy Statement and (d)&#160;all
    directors and executive officers as a group. The information in
    this table is based solely on statements in filings with the
    Securities and Exchange Commission (the &#147;SEC&#148;) or
    other reliable information.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="70%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="7%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=03 type=lead -->
    <TD width="5%" align="right">&nbsp;</TD>	<!-- colindex=03 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=03 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=04 type=lead -->
    <TD width="4%" align="right">&nbsp;</TD>	<!-- colindex=04 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=04 type=hang1 -->
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Amount and Nature of<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Beneficial
    Ownership(2)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Percent<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">Name and Address of Beneficial
    Owner(1)</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Stock</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Options</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">of Class</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <B><FONT style="font-size: 10pt">Directors and Executive
    Officers</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Andrew E. Senyei(8)(9)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,798,783
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    45,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    10.5
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Craig C. Taylor(12)(13)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    841,063
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    30,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    5.0
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Nancy D. Burrus(10)(11)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    615,551
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    30,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    3.7
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Kathleen D. LaPorte(14)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    30,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    *
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Michael P. Downey(15)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    22,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    *
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">C. Gregory Vontz(16)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    22,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    *
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Emory V. Anderson(3)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    256,740
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1.5
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Mark D. Fischer-Colbrie(4)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    129,447
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    *
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Durlin E. Hickok(7)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    980
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    118,482
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    *
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Robert O. Hussa(5)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    17,228
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    25,115
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    *
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Marian E. Sacco(6)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    600
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    153,087
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    *
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <B><FONT style="font-size: 10pt">All directors and executive
    officers as a group (11 persons)(17)</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    3,274,205
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    862,871
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    22.6
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <B><FONT style="font-size: 10pt">5% Stockholders</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Enterprise Partners&#160;V, L.P.(8)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,781,857
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    10.2
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Entities Affiliated with Credit
    Suisse(18)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,569,845
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    9.0
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Arbor Capital Management, LLC(21)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,321,900
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    7.6
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Oberweis Asset Management, Inc.(19)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    981,274
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    5.6
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">M.A. Weatherbie&#160;&#38; Co.,
    Inc.(20)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    882,034
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    5.1
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%; align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="2%"></TD>
    <TD width="2%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    *&#160;&#160;
</TD>
    <TD align="left">
    Less than 1%.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="1%"></TD>
    <TD width="3%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (1)&#160;
</TD>
    <TD align="left">
    Unless otherwise indicated, the address of each of the named
    individuals is c/o&#160;Adeza Biomedical Corporation,
    1240&#160;Elko Drive, Sunnyvale, California 94089.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (2)&#160;
</TD>
    <TD align="left">
    Beneficial ownership of shares is determined in accordance with
    the rules of the SEC and generally includes any shares over
    which a person exercises sole or shared voting or investment
    power, or of which a person has the right to acquire ownership
    within 60&#160;days after March&#160;31, 2006. Except as
    otherwise noted, each person or entity has sole voting and
    investment power with respect to the shares shown.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (3)&#160;
</TD>
    <TD align="left">
    Includes 161,818&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    94,922&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (4)&#160;
</TD>
    <TD align="left">
    Includes 108,354&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    21,093&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (5)&#160;
</TD>
    <TD align="left">
    Includes 14,568&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    10,547&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    7
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="1%"></TD>
    <TD width="3%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (6)&#160;
</TD>
    <TD align="left">
    Includes 131,993&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    21,094&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (7)&#160;
</TD>
    <TD align="left">
    Includes 97,388&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    21,094&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (8)&#160;
</TD>
    <TD align="left">
    Includes 1,781,857&#160;shares held of record by Enterprise
    Partners&#160;V, L.P. Andrew Senyei,&#160;M.D., a member of our
    Board, William Stensrud, Carl J. Eibl, and Robert W. Conn are
    general partners of Enterprise Partners&#160;V, L.P. and may be
    deemed to beneficially own the shares owned by Enterprise
    Partners&#160;V, L.P.; however, each person disclaims beneficial
    ownership of these shares except to the extent of his
    proportionate pecuniary interest therein. The address for
    Enterprise Partners&#160;V, L.P. is 2223 Avenida de la Playa,
    Suite&#160;300, La&#160;Jolla, California 92037,
    attn:&#160;Andrew Senyei.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    (9)&#160;
</TD>
    <TD align="left">
    Includes 16,953&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006 and
    28,047&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006, and 13,941&#160;shares of record held by
    Andrew Senyei, a member of our Board, 995&#160;shares of record
    held by the Alison Marie Senyei Trust, 995&#160;shares of record
    held by the Grant Drew Senyei Trust, and 995&#160;shares of
    record held by the Kelly Joanne Senyei Trust.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (10)&#160;
</TD>
    <TD align="left">    Includes 615,551&#160;shares held of record by STF&#160;II,
    L.P., a fund affiliated with Suez Ventures. Nancy D. Burrus, a
    member of our Board, Guy H. Conger and David E. Gold are general
    partners of STF&#160;II, L.P. and may be deemed to beneficially
    own the shares owned by STF&#160;II, L.P.; however each person
    disclaims beneficial ownership of the shares except to the
    extent of his or her proportionate pecuniary interest therein.
    The address for STF&#160;II, L.P. is 1690&#160;Woodside Road,
    Suite&#160;103, Redwood City, CA 94061.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (11)&#160;
</TD>
    <TD align="left">    Includes 9,688&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    20,312&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (12)&#160;
</TD>
    <TD align="left">    Includes 466,915&#160;shares held of record by Asset Management
    Associates 1984, L.P. and 357,950&#160;shares held of record by
    Asset Management Associates 1989, L.P. Craig Taylor, a member of
    our Board, John Shoch and Franklin P. Johnson,&#160;Jr. are the
    general partners of AMC Partners 84, L.P. and
    Messrs.&#160;Taylor, Shoch, Johnson and Ferrell Sanders are the
    general partners of AMC Partners 89, L.P. AMC Partners 84, L.P.
    is the general partner of Asset Management Associates 1984, L.P.
    and AMC Partners 89, L.P. is the general partner of Asset
    Management Associates 1989, L.P. AMC Partners 84, L.P. and
    Messrs.&#160;Taylor, Shoch and Johnson may be deemed to
    beneficially own the shares owned by Asset Management Associates
    1984, L.P., and AMC Partners 89, L.P. and Messrs.&#160;Taylor,
    Shoch, Johnson and Ferrell may be deemed to beneficially own the
    shares owned by Asset Management Associates; however, each
    entity and person disclaims beneficial ownership of these shares
    except to the extent of his or its proportionate pecuniary
    interest therein. The address for the Asset Management
    Associates funds is 480 Cowper Street, 2nd&#160;Floor, Palo
    Alto, CA 94301.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (13)&#160;
</TD>
    <TD align="left">    Includes 9,688&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    20,312&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (14)&#160;
</TD>
    <TD align="left">    Includes 9,688&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    20,312&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (15)&#160;
</TD>
    <TD align="left">    Includes 6,563&#160;shares underlying options that are
    exercisable within 60&#160;days of March&#160;31, 2006, and
    15,937&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (16)&#160;
</TD>
    <TD align="left">    Includes 938&#160;shares underlying options that are exercisable
    within 60&#160;days of March&#160;31, 2006, and
    21,562&#160;shares underlying options that are exercisable and
    subject to vesting or a right of repurchase within 60&#160;days
    of March&#160;31, 2006.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (17)&#160;
</TD>
    <TD align="left">    Total number of shares includes common stock held by entities
    affiliated with directors and executive officers. See footnotes
    (3)&#160;through (16)&#160;above.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    8
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (18)&#160;
</TD>
    <TD align="left">    The address for the Investment Banking division of Credit Suisse
    is Eleven Madison Avenue, New York, New York 10010. This
    information was obtained from the Schedule&#160;13G/A filed on
    February&#160;14, 2006 with the SEC by Credit Suisse on behalf
    of the Investment Banking division.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (19)&#160;
</TD>
    <TD align="left">    The address for Oberweis Asset Management is 3333 Warrenville
    Road, Suite&#160;500, Lisle, IL 60532. This information was
    obtained from the Schedule&#160;13G filed on February&#160;14,
    2006 with the SEC by Oberweis Asset Management, Inc., James D.
    Oberweis and James W. Oberweis.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (20)&#160;
</TD>
    <TD align="left">    The address for M.A. Weatherbie&#160;&#38; Co., Inc. is 265
    Franklin Street, Suite&#160;1601, Boston, MA 02110. This
    information was obtained from the Schedule&#160;13G filed on
    February&#160;10, 2006 with the SEC by M.A.
    Weatherbie&#160;&#38; Co., Inc.
</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (21)&#160;
</TD>
    <TD align="left">    The address for Arbor Capital Management, LLC is One Financial
    Plaza, 120 South Sixth Street, Suite&#160;1000 Minneapolis, MN
    55402. This information was obtained from the Schedule&#160;13G
    filed on February&#160;3, 2006 with the SEC by Arbor Capital
    Management, LLC and Rick D. Leggott.
</TD>
</TR>

</TABLE>


<!-- link1 "CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">CERTAIN
    RELATIONSHIPS AND RELATED TRANSACTIONS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    From January&#160;1, 2005 until the date of this Proxy
    Statement, there has not been any transaction or series of
    similar transactions, nor is there currently proposed any
    transaction or series of similar transactions, to which we were,
    are, or would be a party, and in which the amount involved
    exceeded or would exceed $60,000 and in which any of our
    directors or executive officers, any holder of more than 5% of
    any class of our voting securities or any member of the
    immediate family of any of these persons had or will have a
    direct or indirect material interest, other than the
    compensation arrangements (including with respect to equity
    compensation as described herein) and the transactions described
    below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Management continuity agreements.</I>&#160;&#160;See
    &#147;Severance and Change of Control
    Agreements&#160;&#151;&#160;Management continuity
    agreements.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Indemnification agreements.</I>&#160;&#160;We have entered
    into indemnification agreements with our directors and executive
    officers for the indemnification of and advancement of expenses
    to these persons to the fullest extent permitted by law. We also
    intend to enter into these agreements with our future directors
    and executive officers.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Other agreements.</I>&#160;&#160;All of our current employees
    and consultants have entered into agreements with us relating to
    the protection of our confidential information and the
    assignment of inventions. None of our employees are employed for
    a specified term and each employee&#146;s employment with us is
    subject to termination at any time by either party for any
    reason, with or without cause, without further liability or
    obligation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Director Compensation.</I>&#160;&#160;See &#147;Director
    Compensation.&#148;
</DIV>


<!-- link1 "SECTION 16( a ) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SECTION&#160;16(a)
    BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under Section&#160;16(a) of the Securities Exchange Act of 1934
    (the &#147;Exchange Act&#148;) and SEC rules, the Company&#146;s
    directors, executive officers and beneficial owners of more than
    10% of any class of equity security are required to file
    periodic reports of their ownership, and changes in that
    ownership, with the SEC. Based solely on its review of copies of
    these reports and representations of such reporting persons, the
    Company believes that during fiscal year 2005, such SEC filing
    requirements were satisfied, except as follows: (i)&#160;each of
    Andrew Senyei, Nancy Burrus, Kathleen LaPorte and Craig Taylor
    filed Forms&#160;4 on June&#160;22, 2005 reporting option grants
    made on June&#160;9, 2005 pursuant to the automatic option grant
    provisions of the 2004 Plan; and (ii)&#160;Marian Sacco filed
    Form&#160;4 on April&#160;10, 2006 reporting an option exercise
    made on December&#160;30, 2005.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    9
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "EXECUTIVE COMPENSATION" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">EXECUTIVE
    COMPENSATION</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following tables and descriptive materials set forth
    information concerning compensation earned for services rendered
    to the Company by the Chief Executive Officer (the
    &#147;CEO&#148;) and the Company&#146;s next four most highly
    compensated executive officers for fiscal years 2003, 2004 and
    2005. Collectively, together with the CEO, these are the
    &#147;named executive officers&#148;.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Summary
    Compensation Table</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="37%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="2%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=03 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=03 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=03 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=04 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=04 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=04 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=05 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=05 type=lead -->
    <TD width="14%" align="right">&nbsp;</TD>	<!-- colindex=05 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=05 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=06 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=06 type=lead -->
    <TD width="11%" align="right">&nbsp;</TD>	<!-- colindex=06 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=06 type=hang1 -->
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Long Term<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Compensation<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Awards</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Annual Compensation</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Securities<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">All Other<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">Name and Principal
    Position(s)</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Year</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Salary ($)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Bonus ($)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Underlying Options(#)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Compensation (1)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Emory V. Anderson
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2005
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    366,599
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    183,300
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">President and Chief Executive
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2004
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    337,209
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    168,605
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    168,750
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Officer
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2003
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    310,277
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    108,597
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Mark D. Fischer-Colbrie
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2005
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    243,055
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    85,069
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Vice President, Finance and
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2004
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    229,839
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    68,952
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    37,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    76,000
</TD>
<TD nowrap align="left" valign="bottom">
    (2)
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Administration and Chief
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2003
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    216,293
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    43,259
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    33,500
</TD>
<TD nowrap align="left" valign="bottom">
    (2)
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Financial Officer
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Durlin E. Hickok
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2005
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    239,736
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    77,914
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Vice President, Medical Affairs
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2004
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    229,412
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    45,882
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    37,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2003
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    218,720
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    43,744
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Robert O. Hussa
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2005
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    207,570
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    31,163
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Vice President, Research and
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2004
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    203,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    20,350
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    18,750
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Development
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2003
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    199,346
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    19,935
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Marian E. Sacco
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2005
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    232,315
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    81,310
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Vice President, Sales and
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2004
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    222,310
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    44,462
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    37,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="color: #000000; background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: 0pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Marketing
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2003
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    209,388
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    41,878
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%; align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    (1) </TD>
    <TD></TD>
    <TD valign="bottom">
    In accordance with the rules of the SEC, the other annual
    compensation disclosed in this table does not include various
    perquisites and other personal benefits received by a named
    executive officer that does not excess the lesser of $50,000 or
    10% of such officer&#146;s salary and bonus disclosed in this
    table.</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR>
    <TD align="right" valign="top">
    (2) </TD>
    <TD></TD>
    <TD valign="bottom">
    Represents forgiveness of loan.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Options/
    Executive Officers</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    None of the named executive officers received options to
    purchase Common Stock or other securities of the Company in the
    fiscal year ended December&#160;31, 2005.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    10
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Aggregated
    Option Exercises And Option Values Table</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table shows information concerning the shares of
    Common Stock subject to stock options exercised by the named
    executive officers in the fiscal year ended December&#160;31,
    2005, and information concerning the value of remaining
    exercisable and unexercisable options held by each of the named
    executive officers at December&#160;31, 2005, on a pre-tax basis.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Aggregated
    Option Exercises In Last Fiscal Year<BR>
    And Fiscal Year-End Option Values</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="31%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="7%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=03 type=lead -->
    <TD width="7%" align="right">&nbsp;</TD>	<!-- colindex=03 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=03 type=hang1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=04 type=lead -->
    <TD width="8%" align="right">&nbsp;</TD>	<!-- colindex=04 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=04 type=hang1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=05 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=05 type=lead -->
    <TD width="8%" align="right">&nbsp;</TD>	<!-- colindex=05 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=05 type=hang1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=06 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=06 type=lead -->
    <TD width="7%" align="right">&nbsp;</TD>	<!-- colindex=06 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=06 type=hang1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=07 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=07 type=lead -->
    <TD width="8%" align="right">&nbsp;</TD>	<!-- colindex=07 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=07 type=hang1 -->
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Value of Unexercised<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Shares<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Number of Unexercised<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt"><FONT style="white-space: nowrap">In-the-Money</FONT>
    Options<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Acquired on<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Value<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Options at December&#160;31,
    2005</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="6" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">at December&#160;31,
    2005(3)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">Name</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Exercise</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Realized(1)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Exercisable(2)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Unexercisable</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Exercisable</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Unexercisable</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Emory V. Anderson
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    293,929
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    4,309,858
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    144,240
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    112,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    2,180,745
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    1,243,125
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Mark D. Fischer-Colbrie
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    40,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    587,800
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    101,947
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    27,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,739,801
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    303,875
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Durlin E. Hickok
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    50,980
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    823,465
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    93,482
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    25,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,601,404
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    276,250
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Robert O. Hussa
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    40,503
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    631,037
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    20,215
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    12,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    349,480
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    138,125
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Marian E. Sacco
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    20,600
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    225,517
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    128,087
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    25,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2,471,493
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    276,250
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%; align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    (1) </TD>
    <TD></TD>
    <TD valign="bottom">
    The value realized upon exercise is determined by subtracting
    the exercise price from the fair market value at the time the
    option is exercised.</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR>
    <TD align="right" valign="top">
    (2) </TD>
    <TD></TD>
    <TD valign="bottom">
    Each of the outstanding options listed may be exercised at any
    time, whether vested or unvested. Upon the exercise of an
    unvested option or the unvested portion of an option, the holder
    will receive shares of restricted stock that are subject to our
    repurchase right at the original purchase price of the shares.
    The repurchase right lapses in accordance with the vesting
    schedule applicable to the option.</TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR>
    <TD align="right" valign="top">
    (3) </TD>
    <TD></TD>
    <TD valign="bottom">
    Based on the closing price of the common stock as reported on
    the Nasdaq National Market at December&#160;31, 2005, less the
    exercise price, multiplied by the number of shares underlying
    the option.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Liability and Indemnification of Officers and
    Directors</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our amended and restated certificate of incorporation limits the
    liability of our directors to the maximum extent permitted by
    Delaware law. Delaware law provides that a corporation may
    eliminate the personal liability of its directors for monetary
    damages for breach of their fiduciary duties as directors,
    except liability for any of the following acts:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="1%"></TD>
    <TD width="95%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    breach of their duty of loyalty to us or our stockholders;
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    acts or omissions not in good faith or that involve intentional
    misconduct or a knowing violation of law;
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    unlawful payments of dividends or unlawful stock repurchases or
    redemptions;&#160;and
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    any transaction from which the director derived an improper
    personal benefit.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our bylaws provide that we will indemnify our directors,
    officers, employees and other agents to the fullest extent
    permitted by the Delaware General Corporation Law. Our bylaws
    also permit us to secure insurance on behalf of any officer,
    director, employee or other agent of ours for any liability
    arising out of his or her actions in such capacity, regardless
    of whether the Delaware General Corporation Law would permit a
    corporation to indemnify for such liability.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We have obtained directors&#146; and officers&#146; insurance
    providing indemnification for all of our directors and officers
    for certain liabilities. We believe that these provisions and
    this insurance are necessary to attract and retain qualified
    directors and officers. At present, there is no pending
    litigation or proceeding involving any of our directors,
    officers, employees or agents where indemnification would be
    required or permitted. We are not aware of any pending or
    threatened litigation or proceeding that might result in a claim
    for such indemnification.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    11
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Severance
    and Change of Control Agreements&#160;&#151;&#160;Management
    continuity agreements</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We have entered into a management continuity agreement with each
    of Mr.&#160;Anderson, Mr.&#160;Fischer-Colbrie, Dr.&#160;Hickok,
    Dr.&#160;Hussa and Ms.&#160;Sacco. Mr.&#160;Anderson&#146;s
    agreement provides that if we experience a &#147;change of
    control&#148; (as defined in the agreement), the vesting of each
    equity award granted to Mr.&#160;Anderson shall accelerate such
    that 75% of the aggregate number of unvested awards shall become
    vested immediately prior to the effective date of the
    transaction. In the event that Mr.&#160;Anderson&#146;s
    employment is terminated other than for &#147;cause&#148; or if
    he resigns for &#147;good reason&#148; (each as defined in the
    agreement) at any time within 12&#160;months following a change
    of control, each equity award shall become 100% vested as of the
    termination date. In addition, Mr.&#160;Anderson will receive
    severance benefits equal to 18&#160;months of his salary, a lump
    sum payment equal to 75% of the bonus payment made to
    Mr.&#160;Anderson for the prior fiscal year and continuation of
    his health insurance benefits at our expense under COBRA for up
    to 18&#160;months. In the event that Mr.&#160;Anderson&#146;s
    termination or resignation occurs for one of the reasons
    specified above, at any time prior to, or more than
    12&#160;months following, a change of control, he will receive
    severance benefits equal to 12&#160;months of his base salary,
    50% of the prior year&#146;s bonus, continuation of his health
    insurance benefits at our expense under COBRA for up to
    12&#160;months, and 12&#160;months acceleration of his unvested
    equity awards. In both cases, equity awards granted on or after
    July 2004 shall remain exercisable for 18&#160;months following
    his termination date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Mr.&#160;Fischer-Colbrie&#146;s agreement provides that if we
    experience a &#147;change of control&#148; (as defined in the
    agreement), the vesting of each equity award granted to
    Mr.&#160;Fischer-Colbrie shall accelerate such that 50% of the
    aggregate number of unvested awards shall become vested
    immediately prior to the effective date of the transaction. In
    the event that Mr.&#160;Fischer-Colbrie&#146;s employment is
    terminated other than for &#147;cause&#148; or if he resigns for
    &#147;good reason&#148; (each as defined in the agreement) at
    any time within 12&#160;months following a change of control,
    each equity award shall become 100% vested as of his termination
    date. In addition, Mr.&#160;Fischer-Colbrie will receive
    severance benefits equal to 12&#160;months of his salary, a lump
    sum payment equal to 50% of the bonus payment made to
    Mr.&#160;Fischer-Colbrie for the prior fiscal year and
    continuation of his health insurance benefits at our expense
    under COBRA for up to 12&#160;months. In the event that
    Mr.&#160;Fischer-Colbrie&#146;s termination or resignation
    occurs for one of the reasons specified above at any time prior
    to, or more than 12&#160;months following, a change of control,
    he will receive severance benefits equal to 6&#160;months of his
    base salary, 25% of the prior year&#146;s bonus, continuation of
    his health insurance benefits at our expense under COBRA for up
    to 6&#160;months, and 12&#160;months acceleration of his
    unvested equity awards. In both cases, equity awards granted on
    or after July 2004 shall remain exercisable for 18&#160;months
    following his termination date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the agreements with Dr.&#160;Hickok, Dr.&#160;Hussa and
    Ms.&#160;Sacco, if we experience a &#147;change of control&#148;
    (as defined in the agreement), the vesting of each equity award
    granted to the officer shall accelerate such that 50% of the
    aggregate number of unvested awards shall become immediately
    vested immediately prior to the effective date of the
    transaction. In the event that the officer&#146;s employment is
    terminated other than for &#147;cause&#148; or if he or she
    resigns for &#147;good reason&#148; (each as defined in the
    agreements) at any time within 12&#160;months following a change
    of control, the officer will receive severance benefits equal to
    9&#160;months of his or her salary, a lump sum payment equal to
    37.5% of the bonus payment made to the officer for the prior
    fiscal year, continuation of his or her health insurance
    benefits at our expense under COBRA for up to 9&#160;months and
    12&#160;months acceleration of his or her unvested equity
    awards. In addition, equity awards granted on or after July 2004
    shall remain exercisable for 18&#160;months following his or her
    termination date. In the event that the officer&#146;s
    termination or resignation occurs for one of the reasons
    specified above, at any time prior to, or more than
    12&#160;months following, a change of control, he or she will
    receive severance benefits equal to 6&#160;months of his or her
    base salary, 25% of the prior year&#146;s bonus and continuation
    of his or her health insurance benefits at our expense under
    COBRA for up to 6&#160;months.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each of these agreements further provides that, to the extent
    the severance payments and benefits payable under the agreements
    would cause the officer to be liable for &#147;parachute
    payment&#148; excise taxes applicable by reason of
    Section&#160;4999 of the Internal Revenue Code, the officer will
    receive an additional &#147;gross up&#148; payment to indemnify
    the officer for the effect of the excise taxes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As a condition of receipt of the severance payments and benefits
    under the agreements, each officer must execute a release of
    claims agreement in the form we provide and confirm his or her
    obligations to us under our standard form of proprietary
    information agreement.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    12
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">COMPENSATION
    COMMITTEE REPORT ON EXECUTIVE COMPENSATION</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The purpose of the compensation committee under a written
    charter adopted by the Board is to assist the Board in the
    discharge of its responsibilities relating to executive and
    director compensation, and to oversee incentive, equity-based
    and other compensatory plans in which executive officers and key
    employees of the Company participate. The current members of the
    compensation committee are Andrew E. Senyei, Nancy D. Burrus and
    Michael P. Downey, each of whom is a &#147;non-employee
    director&#148; within the meaning of Section&#160;16 of the
    Securities and Exchange Act and an &#147;outside director&#148;
    within the meaning of Section&#160;162(m) of the Internal
    Revenue Code. Mr.&#160;Downey joined the Board and was appointed
    to the compensation committee in March 2005. In performing its
    duties, the compensation committee reviews reports and
    recommendations presented by management, and from time to time
    considers information obtained from outside firms or consultants
    to assist it in the review of compensation levels, structure and
    design. The Company&#146;s compensation policy for executive
    officers is to offer a total compensation package that aligns
    compensation with business objectives and performance and
    enables the Company to attract, retain and reward executive
    officers, whose contributions are necessary for the long term
    success of the Company. As a result, compensation may consist of
    salary and bonus, which provide current incentives, and stock
    options, which provide longer-term incentives.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Base
    Salary and Cash Bonus</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Base salaries for new management employees are determined
    initially by evaluating the responsibilities of the position
    held and the experience of the individual, and by reference to
    the competitive marketplace for managerial talent, including a
    comparison of base salaries for comparable positions at similar
    companies of comparable size and capitalization. Annual salary
    adjustments are determined by evaluating the competitive
    marketplace, the performance of the Company, the performance of
    the executive and the operational areas of the Company for which
    the executive is responsible, and the responsibilities assumed
    by the executive. Cash bonus awards are based on the performance
    of the executive, the performance of the operational groups
    reporting to the executive and the performance of the Company.
    The compensation to be paid to any individual executive has not
    been based on any particular mathematical formula. Rather, the
    compensation committee reviews objectives, accomplishments,
    performance and compensation as a whole for each executive (and
    all executives), as well as the recommendations of the Chief
    Executive Officer with respect to other executives, and makes
    appropriate compensation determinations in the exercise of its
    business judgment.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Equity
    Compensation</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The compensation committee believes that equity-based
    compensation in the form of stock options aligns the interests
    of executives with the long-term interests of the Company&#146;s
    stockholders by encouraging executive officers to acquire a
    proprietary interest in the Company. The compensation committee
    further believes that the use of vesting periods encourages
    retention of executive officers, and accordingly stock options
    granted to executive officers generally vest over time. Stock
    options are granted to executive officers on a discretionary
    basis, at varying times and in varying amounts, with an exercise
    price that is equal to the market price of the Company&#146;s
    common stock at the time of grant. The size and the timing of
    each grant are based on a number of factors, including the
    Company&#146;s achievement of specific milestones, the
    individual&#146;s level of responsibility, the amount, exercise
    price and term of options already held by the individual, the
    individual&#146;s contributions to the achievement of the
    Company&#146;s financial and strategic objectives, and industry
    practices and norms. In light of equity compensation awards made
    to executives in 2004, the compensation committee elected not to
    make equity compensation awards to executives in 2005.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Chief
    Executive Officer&#146;s Compensation</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In 2005, Emory V. Anderson, the Company&#146;s President and
    Chief Executive Officer, received a salary increase of
    approximately 5.75% over his 2004 salary. The committee believes
    that Mr.&#160;Anderson&#146;s salary is currently below the
    mid-range of salaries for chief executive officers of other
    public technology-based companies of similar size and in the
    same geographic region as the Company. In 2005,
    Mr.&#160;Anderson provided strong leadership to the Company in
    its achievement of strategic and financial objectives.
    Mr.&#160;Anderson&#146;s bonus for 2005 reflects his important
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    13
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    contributions to the Company&#146;s success in 2005, including
    the continued strong growth of the Company&#146;s business, in
    both revenue and net income.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Effect of
    Section&#160;162(m) of the Internal Revenue Code</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;162(m) of the Internal Revenue Code limits to
    $1,000,000&#160;per person the amount that the Company may
    deduct in any taxable year for compensation paid to the Chief
    Executive Officer and any of the four other most highly
    compensated officers. Under the Treasury Regulations
    corresponding to Section&#160;162(m) of the Internal Revenue
    Code, compensation received through the exercise of an option
    will not be subject to the $1,000,000 limit if it qualifies as
    &#147;qualified performance-based compensation&#148; within the
    meaning of Section&#160;162(m). The Company&#146;s 1995 Stock
    Option and Restricted Stock Plan and the 2004 Equity Incentive
    Plan were approved by the Company&#146;s stockholders in order
    for stock options with an exercise price equal to the fair
    market value of the option shares on the grant date granted
    under such plans to meet the Section&#160;162(m) requirements
    for &#147;qualified performance-based compensation&#148; and
    therefore be exempted from the limitation on deductibility. The
    compensation committee believes that the best interests of the
    Company and its stockholders will be served if the
    Company&#146;s stock-based long-term incentives qualify as
    &#147;qualified performance-based compensation.&#148; It is the
    compensation committee&#146;s intention that, so long as it is
    consistent with the Company&#146;s overall compensation
    objectives, virtually all executive compensation will be
    deductible by the Company for federal income tax purposes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    THE COMPENSATION COMMITTEE
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Andrew E. Senyei, MD, Chair
</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Nancy D. Burrus
</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Michael P. Downey
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Equity
    Compensation Plan Information</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table provides information as of December&#160;31,
    2005 with respect to the shares of the Company&#146;s Common
    Stock that may be issued under all of the Company&#146;s
    existing equity compensation plans, including its 1995 Stock
    Option and Restricted Stock Plan and its 2004 Equity Incentive
    Plan.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="38%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="16%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=03 type=lead -->
    <TD width="13%" align="right">&nbsp;</TD>	<!-- colindex=03 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=03 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=04 type=lead -->
    <TD width="19%" align="right">&nbsp;</TD>	<!-- colindex=04 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=04 type=hang1 -->
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">(a)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">(b)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">(c)</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Number of Securities<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Remaining Available for<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Future Issuance under<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Number of Securities to<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Weighted Average<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Equity Compensation Plans<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Be Issued upon Exercise<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">Exercise Price of<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B><FONT style="font-size: 8pt">(Excluding Securities<BR>
    </FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 8pt">Plan Category</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">of Outstanding Options</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Outstanding Options</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">Reflected in
    Column(a))</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">1995 Stock Option and Restricted
    Stock Plan
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,286,154
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    6.13
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    &#151;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">2004 Equity Incentive Plan
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    382,534
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    16.60
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2,035,208
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="font-size: 1pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Total
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,668,688
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    8.53
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2,035,208
</TD>
<TD nowrap align="left" valign="bottom">
    (1)
</TD>
</TR>
<TR valign="bottom" style="font-size: 1pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%; align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    (1) </TD>
    <TD></TD>
    <TD valign="bottom">
    Includes a total of 2,035,208&#160;shares of Common Stock
    remaining available for future issuance under the Company&#146;s
    2004 Equity Incentive Plan as of December&#160;31, 2005. The
    2004 Equity Incentive Plan contains an &#147;evergreen&#148;
    provision that automatically increases on January 1 of each
    year, the lesser of an additional (a)&#160;3% of the number of
    the Company&#146;s shares issued and outstanding as of the
    preceding December&#160;31, (b)&#160;525,000&#160;shares and
    (c)&#160;a number of shares set by the Board. In addition,
    shares subject to options that expire unexercised under the 1995
    Stock Option and Restricted Stock Plan will be available for
    grant under the 2004 Equity Incentive Plan. There were no shares
    available for future issuance under the Company&#146;s 1995
    Stock Option and Restricted Stock Plan as of December&#160;31,
    2005.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    14
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "REPORT OF THE AUDIT COMMITTEE" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">REPORT OF
    THE AUDIT COMMITTEE</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the guidance of a written charter adopted by the Board, a
    copy of which is available at the Company&#146;s website at
    <I>http://www.adeza.com</I>, the purpose of the audit committee
    is to oversee the accounting and financial reporting processes
    of the Company and audits and reviews of its financial
    statements. The responsibilities of the audit committee include
    appointing and providing for the compensation of the
    Company&#146;s independent registered public accounting firm.
    Each of the members of the audit committee meets the
    independence requirements of Nasdaq.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The audit committee members are not professional accountants or
    auditors, and their functions are not intended to duplicate or
    to certify the activities of management or the independent
    registered public accounting firm, nor can the audit committee
    certify that the independent registered public accounting firm
    is &#147;independent&#148; under applicable rules. The audit
    committee serves a board-level oversight role in which it
    provides advice, counsel and direction to management and the
    independent registered public accounting firm on the basis of
    the information it receives, discussions with management and the
    independent registered public accounting firm, and the
    experience of the audit committee&#146;s members in business,
    financial and accounting matters.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Management has primary responsibility for the system of internal
    controls and the financial reporting process. The independent
    registered public accounting firm has the responsibility to
    express an opinion on the financial statements of the Company
    based on an audit conducted in accordance with the standards of
    the Public Company Accounting Oversight Board (United States).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In this context and in connection with the audited financial
    statements contained in the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K,</FONT>
    the audit committee:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="1%"></TD>
    <TD width="95%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    reviewed and discussed the audited financial statements and
    management&#146;s assessment of the effectiveness of internal
    control over financial reporting as of and for the fiscal year
    ended December&#160;31, 2005 with the Company&#146;s management
    and with Ernst&#160;&#38; Young LLP, the Company&#146;s
    independent registered public accounting firm, including a
    discussion of the quality and acceptability of the
    Company&#146;s financial and disclosure reporting and controls,
    including the nature and extent of the disclosures in the
    financial statements;
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    discussed with Ernst&#160;&#38; Young LLP their judgments as to
    the quality and acceptability of the Company&#146;s financial
    reporting and such other matters as are required to be discussed
    with the audit committee under generally accepted auditing
    standards, including Statement on Auditing Standards
    No.&#160;61, Communication with Audit Committees, and Statement
    on Auditing Standards No.&#160;90, Audit Committee
    Communications;
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    reviewed the written disclosures and the letter from
    Ernst&#160;&#38; Young LLP required by the Independence
    Standards Board Standard No.&#160;1, Independence Discussions
    with Audit Committees, discussed with Ernst&#160;&#38; Young LLP
    their independence, and concluded that any non-audit services
    performed by Ernst&#160;&#38; Young LLP are compatible with
    maintaining their independence;
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    met and discussed with Ernest&#160;&#38; Young LLP (i)&#160;the
    overall scope, plans and estimated costs of their audit
    (ii)&#160;the results of their examinations including their
    evaluation of the Company&#146;s internal controls, and the
    overall quality of the Company&#146;s financial reporting, and
    (iii)&#160;their reviews of the Company&#146;s quarterly
    financial statements;
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    met and discussed with the Company&#146;s management drafts of
    the Company&#146;s quarterly and annual reports, and drafts of
    the respective press releases disclosing the financial
    highlights of the Company;
</TD>
</TR>

<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    based on the foregoing reviews and discussions, recommended to
    the Board that the audited financial statements be included in
    the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2005 filed with the
    Securities and Exchange Commission;&#160;and
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    15
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="1%"></TD>
    <TD width="95%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    instructed Ernst&#160;&#38; Young LLP that the audit committee
    expects to be advised if there are any subjects that require
    special attention.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The audit committee held 7 meetings with management and
    Ernst&#160;&#38; Young LLP in fiscal 2005.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    THE AUDIT COMMITTEE
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Michael P. Downey
</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Nancy D. Burrus
</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Craig C. Taylor
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Principal
    Accountant Fees and Services</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The audit committee has appointed Ernst&#160;&#38; Young LLP as
    the Company&#146;s independent registered public accounting firm
    for the year ending December&#160;31, 2005.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table shows the fees paid or accrued by the
    Company for the audit and other services provided by
    Ernst&#160;&#38; Young LLP for fiscal 2005 and 2004.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="75%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=03 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=03 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=03 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=04 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=04 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=04 type=hang1 -->
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">2005</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B><FONT style="font-size: 8pt">2004</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Audit Fees(1)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    831,917
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    949,938
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <FONT style="font-size: 10pt">Tax Fees(2)
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    66,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    46,642
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="font-size: 1pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 20pt">
    <FONT style="font-size: 10pt">Total
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    898,417
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    996,580
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="font-size: 1pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%; align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    (1) </TD>
    <TD></TD>
    <TD valign="bottom">
    Audit fees represent fees for professional services provided in
    connection with the audit of the Company&#146;s financial
    statements and review of the Company&#146;s quarterly financial
    statements and audit services provided in connection with other
    statutory or regulatory filings.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    (2)&#160;</TD>
    <TD align="left">
    For 2005 and 2004 tax fees principally related to preparation
    services for Federal and State returns.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The audit committee has delegated to the Chair of the audit
    committee the authority to pre-approve services not prohibited
    by law to be performed by the Company&#146;s independent
    registered public accounting firm and associated fees, provided
    that the Chair shall report any decision to pre-approve such
    services and fees to the full audit committee at its next
    regular meeting.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    16
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "PERFORMANCE GRAPH" -->


<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">PERFORMANCE
    GRAPH</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following graph compares the cumulative total stockholder
    return data for the Company&#146;s common stock since
    December&#160;10, 2004 (the date on which the Company&#146;s
    common stock was first traded on the Nasdaq National Market) to
    the cumulative return over such period of (i)&#160;The Nasdaq
    Stock Market Composite Index, and (ii)&#160;the Nasdaq Medical
    Device Index. The graph assumes that $100 was invested on the
    date on which the Company completed the initial public offering
    of its common stock, in the common stock and in each of the
    comparative indices. The graph further assumes that such amount
    was initially invested in the Common Stock of the Company at
    $16.00, the price to which such stock was first offered to the
    public by the Company on the date of its initial public
    offering, and reinvestment of any dividends. The stock price
    performance on the following graph is not necessarily indicative
    of future stock price performance.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">COMPARISON
    OF CUMULATIVE TOTAL RETURN*<BR>
    Among Adeza Biomedical Corporation, the Nasdaq Stock Market
    (U.S.) Index,<BR>
    and the Nasdaq Medical Equipment Index</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <IMG src="f19772def1977202.gif" alt="(PERFORMANCE GRAPH)" >
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="2%"></TD>
    <TD width="98%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>    *&#160;</TD>
    <TD align="left">
    $100 invested on 12/10/04 in stock or on 11/30/04 in
    index-including reinvestment of dividends. Fiscal year ending
    December&#160;31.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    17
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->


<!-- link1 "PROPOSAL 1 &#151; ELECTION OF DIRECTORS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">PROPOSAL&#160;1&#160;&#151;&#160;ELECTION
    OF DIRECTORS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At the Annual Meeting, the stockholders will vote on the
    election of two Class&#160;II directors to serve for a
    three-year term until the annual meeting of stockholders in 2009
    and until their successors are elected and qualified. The Board
    has unanimously nominated Andrew E. Senyei, MD and Michael P.
    Downey for election to the Board as Class&#160;II directors. The
    nominees have indicated that they are willing and able to serve
    as directors. If Andrew E. Senyei, MD and Michael P. Downey
    becomes unable or unwilling to serve, the accompanying proxy may
    be voted for the election of such other person as shall be
    designated by the Board. The proxies being solicited will be
    voted for no more than two nominees at the Annual Meeting. The
    Class&#160;II Directors will be elected by a plurality of the
    votes cast, in person or by proxy, at the Annual Meeting,
    assuming a quorum is present. Stockholders do not have
    cumulative voting rights in the election of directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>The Board recommends a vote &#147;for&#148; the election of
    Andrew E. Senyei, MD and Michael P. Downey as class&#160;II
    directors.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Unless otherwise instructed, it is the intention of the persons
    named in the accompanying proxy card to vote shares represented
    by properly executed proxy cards for the election of Andrew E.
    Senyei, MD and Michael P. Downey.
</DIV>


<!-- link1 "PROPOSAL 2 &#151; RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">PROPOSAL&#160;2&#160;&#151;&#160;RATIFICATION
    OF INDEPENDENT REGISTERED<BR>
    PUBLIC ACCOUNTING FIRM</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At the Annual Meeting, the stockholders will be asked to ratify
    the appointment of Ernst&#160;&#38; Young LLP as the
    Company&#146;s independent registered public accounting firm for
    the fiscal year ending December&#160;31, 2006. Representatives
    of Ernst&#160;&#38; Young LLP are expected to be present at the
    Annual Meeting and will have the opportunity to make statements
    if they desire to do so. Such representatives are also expected
    to be available to respond to appropriate questions.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>The Board recommends a vote &#147;for&#148; the ratification
    of the appointment of Ernst&#160;&#38; Young LLP as the
    Company&#146;s independent registered public accounting firm for
    the fiscal year ending December&#160;31, 2006.</B>
</DIV>


<!-- link1 "OTHER MATTERS" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">OTHER
    MATTERS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of the time of preparation of this Proxy Statement, neither
    the Board nor management intends to bring before the meeting any
    business other than the matters referred to in the Notice of
    Annual Meeting and this Proxy Statement. If any other business
    should properly come before the meeting, or any adjournment
    thereof, the persons named in the proxy will vote on such
    matters according to their best judgment.
</DIV>


<!-- link1 "STOCKHOLDER PROPOSALS FOR 2007 ANNUAL MEETING" -->


<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">STOCKHOLDER
    PROPOSALS&#160;FOR 2007 ANNUAL MEETING</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company&#146;s Bylaws provide that advance notice of a
    stockholder&#146;s proposal must be delivered to the Secretary
    of the Company at the Company&#146;s principal executive offices
    not less than 120&#160;days, and not more than 150&#160;days,
    prior to the first anniversary of the mailing date of the proxy
    materials for the previous year&#146;s annual meeting. Each
    stockholder&#146;s notice must contain the following information
    as to each matter the stockholder proposes to bring before the
    annual meeting: (a)&#160;as to each person whom the stockholder
    proposes to nominate for election or reelection as a director
    all information relating to such person as would be required to
    be disclosed in solicitations of proxies for the election of
    such nominees as directors pursuant to Regulation&#160;14A under
    the Exchange Act, and such person&#146;s written consent to
    serving as director if elected; (b)&#160;as to any other
    business that the stockholder proposes to bring before the
    meeting, a brief description of such business, the reasons for
    conducting such business at the meeting and any material
    interest in such business of such stockholder and the beneficial
    owner, if any, on whose behalf the proposal is made; and
    (c)&#160;as to the stockholder giving the notice and the
    beneficial owner, if any, on whose behalf the nomination or
    proposal is made (i)&#160;the name and address of such
    stockholder, as they appear on the Company&#146;s books, and of
    such beneficial owner, (ii)&#160;the class and number of shares
    of the Company that are owned beneficially and of record by such
    stockholder and such beneficial owner, and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    18
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN LOGICAL PAGE -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (iii)&#160;whether either such stockholder or beneficial owner
    intends to deliver a proxy statement and form of proxy to
    holders of, in the case of a proposal, at least the percentage
    of the Company&#146;s voting shares required under applicable
    law to carry the proposal, or, in the case of a nomination or
    nominations, a sufficient number of holders of the
    Company&#146;s voting shares to elect such nominee or nominees.
    A copy of the full text of the provisions of the Company&#146;s
    Bylaws dealing with stockholder nominations and proposals is
    available to stockholders from the Secretary of the Company upon
    written request.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the rules of the Securities and Exchange Commission,
    stockholders who wish to submit proposals for inclusion in the
    Proxy Statement of the Board for the 2007 Annual Meeting of
    Stockholders must submit such proposals so as to be received by
    the Company at 1240 Elko Drive, Sunnyvale, California 94089, on
    or before February&#160;6, 2007. In addition, if the Company is
    not notified by February&#160;6, 2007, of a proposal to be
    brought before the 2007 Annual Meeting by a stockholder, then
    proxies held by management may provide the discretion to vote
    against such proposal even though it is not discussed in the
    proxy statement for such meeting.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 52%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    By Order of the Board of Directors
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 52%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <IMG src="f19772def1977201.gif" alt="-s- Emory V. Anderson" >
</DIV>

<DIV align="left" style="margin-left: 52%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Emory V. Anderson
</DIV>

<DIV align="left" style="margin-left: 52%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV align="left" style="margin-left: 52%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    President, Chief Executive Officer and Secretary
</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Sunnyvale, California
</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    April&#160;28, 2006
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">YOUR VOTE
    IS IMPORTANT!</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE
    COMPLETE, SIGN, DATE AND MAIL PROMPTLY THE ACCOMPANYING PROXY
    CARD IN THE ENCLOSED RETURN ENVELOPE, WHICH REQUIRES NO POSTAGE
    IF MAILED IN THE UNITED STATES. THIS WILL ENSURE THE PRESENCE OF
    A QUORUM AT THE MEETING. IF YOU ATTEND THE MEETING, YOU MAY VOTE
    IN PERSON IF YOU WISH TO DO SO EVEN IF YOU HAVE PREVIOUSLY SENT
    IN YOUR PROXY CARD.</B>
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    19
</DIV><!-- END LOGICAL PAGE -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: Helvetica,Arial,sans-serif">





<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ADEZA BIOMEDICAL CORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ANNUAL MEETING OF STOCKHOLDERS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Tuesday, June&nbsp;6, 2006</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>11:00&nbsp;a.m.</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="58%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="bottom"><DIV style="margin-left:0px; text-indent:-0px"><IMG src="f19772def1977203.gif" alt="(ADEZA LOGO)">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom"><B>Adeza Biomedical Corporation<BR>
1240 Elko Drive<BR>
Sunnyvale, CA 94089</B></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom"><FONT style="font-size:16pt"><B>proxy</B></FONT></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 1pt; width: 100%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Proxy Solicited by the Board of Directors for the Annual Meeting of Stockholders to be Held June&nbsp;6, 2006</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The undersigned hereby appoints Emory V. Anderson and Mark D. Fischer-Colbrie or any one of them
with full power of substitution, proxies to vote at the Annual Meeting of Stockholders of Adeza
Biomedical Corporation (the &#147;Company&#148;) to be held on June&nbsp;6, 2006 at 11:00&nbsp;a.m., local time, and at
any adjournment thereof, hereby revoking any proxies heretofore given, to vote all shares of Common
Stock of the Company held or owned by the undersigned as directed on the reverse side of this proxy
card, and in their discretion upon such other matters as may come before the meeting.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><I>See reverse for voting instructions.</I>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif"></DIV>



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="70%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="0" valign="top" align="left"><P>
<DIV style="width: 100%; border: 1px solid black; padding: 3px;"><B>COMPANY #<BR><BR></B></DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>There are three ways to vote your Proxy</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Your telephone or Internet vote authorizes the Named Proxies to vote your shares in the same
manner as if you marked, signed and returned your proxy card.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>VOTE BY PHONE &#151; TOLL FREE &#151; 1-800-560-1965 &#151; QUICK * * * EASY * * * IMMEDIATE</B>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Use any touch-tone telephone to vote your proxy 24 hours a day, 7&nbsp;days a week, until
12:00&nbsp;p.m. (CT)&nbsp;on June&nbsp;5, 2006.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Please have your proxy card and the last four digits of your Social Security Number
or Tax Identification Number available. Follow the simple instructions the voice provides you.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>VOTE BY INTERNET &#151; http://www.eproxy.com/adza/ &#151; QUICK * * * EASY * * * IMMEDIATE</B>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Use the Internet to vote your proxy 24 hours a day, 7&nbsp;days a week until 12:00&nbsp;p.m.
(CT)&nbsp;on June&nbsp;5, 2006.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Please have your proxy card and the last four digits of your Social Security Number
or Tax Identification Number available. Follow the simple instructions to obtain your records
and create an electronic ballot.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>VOTE BY MAIL</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Mark, sign and date your proxy card and return it in the postage-paid envelope we&#146;ve provided or
return it to <B>Adeza Biomedical Corporation, </B>c/o Shareowner Services<SUP style="font-size: 85%; vertical-align: text-top">SM</SUP>, P.O. Box 64873,
St. Paul, MN 55164-0873.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>If you vote by Phone or Internet, please do not mail your Proxy Card</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="16%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="right" valign="bottom"><DIV style="margin-left:0px; text-indent:-0px"><IMG src="f19772dedownarrow.gif" alt="(ARROW)">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><I>Please detach here</I>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom"><IMG src="f19772dedownarrow.gif" alt="(ARROW)"></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="border-bottom: 1px dashed #000000; font-size: 1px">&nbsp;</DIV></DIV>



<DIV align="center" style="font-size: 8pt; margin-top: 18pt"><B>The Board of Directors Recommends a Vote FOR Items 1 &#038; 2.</B>
</DIV>

<P><DIV style="position: relative; float: left; width: 58%">

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 8pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To elect as Class&nbsp;II directors, to hold office until the 2009
Annual Meeting of Stockholders and until their successors are
elected and qualified, the nominees listed below:</TD>
</TR>

</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="58%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">01
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Andrew E. Senyei, MD
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">02
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael P. Downey</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 8pt; margin-top: 6pt"><B>(Instructions: To withhold authority to vote for any indicated
nominee, write the number(s) of the nominee(s) in the box provided
to the right.)</B>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 8pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To ratify the appointment of Ernst &#038; Young LLP as the Company&#146;s
independent registered public accounting firm for the fiscal
year ending December&nbsp;31, 2006.</TD>
</TR>

</TABLE>
</DIV>
</DIV>
<DIV style="position: relative; float: right; width: 40%">
<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT face="Wingdings" style="font-size: 17pt">&#111;</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vote FOR all<BR>
nominees<BR>
(except as marked)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT face="Wingdings" style="font-size: 17pt">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vote WITHHELD<BR>
from all nominees</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="9" valign="top" align="left"><P>
<DIV style="width: 100%; border: 1px solid black; padding: 11px;"></DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT face="Wingdings" style="font-size: 17pt">&#111;</FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">For
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT face="Wingdings" style="font-size: 17pt">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Against
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT face="Wingdings" style="font-size: 17pt">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Abstain</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

</DIV>
<BR clear="all"><BR>

<DIV align="left" style="font-size: 8pt; margin-top: 6pt">The Board recommends that you vote FOR the above proposals. This proxy, when properly executed,
will be voted in the manner directed above. <B>WHEN NO CHOICE IS INDICATED, THIS PROXY WILL BE VOTED
FOR THE ABOVE PROPOSALS. </B>This proxy may be revoked by the undersigned at any time, prior to the
time it is voted by any of the means described in the accompanying proxy statement.
</DIV>
<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="62%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="42%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Address Change? Mark Box&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings" style="font-size: 17pt">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate changes below:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">Date</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><P>
<DIV style="width: 100%; border: 1px solid black; padding: 11px;"></DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Signature(s) in Box<BR>
Date and sign exactly as name(s) appear(s) on
this proxy. If signing for estates, trusts,
corporations or other entities, title or
capacity should be stated. If shares are held
jointly, each holder should sign.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>PLEASE COMPLETE, DATE AND SIGN THIS PROXY AND
RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE.</B></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>f19772def1977201.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f19772def1977201.gif
M1TE&.#EASP`B`/?_````````,P``9@``F0``S```_P`S```S,P`S9@`SF0`S
MS``S_P!F``!F,P!F9@!FF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9_P#,``#,
M,P#,9@#,F0#,S`#,_P#_``#_,P#_9@#_F0#_S`#__S,``#,`,S,`9C,`F3,`
MS#,`_S,S`#,S,S,S9C,SF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F_S.9`#.9
M,S.99C.9F3.9S#.9_S/,`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_9C/_F3/_
MS#/__V8``&8`,V8`9F8`F68`S&8`_V8S`&8S,V8S9F8SF68SS&8S_V9F`&9F
M,V9F9F9FF69FS&9F_V:9`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;,9F;,F6;,
MS&;,_V;_`&;_,V;_9F;_F6;_S&;__YD``)D`,YD`9ID`F9D`S)D`_YDS`)DS
M,YDS9IDSF9DSS)DS_YEF`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF99IF9F9F9
MS)F9_YG,`)G,,YG,9IG,F9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G__\P``,P`
M,\P`9LP`F<P`S,P`_\PS`,PS,\PS9LPSF<PSS,PS_\QF`,QF,\QF9LQFF<QF
MS,QF_\R9`,R9,\R99LR9F<R9S,R9_\S,`,S,,\S,9LS,F<S,S,S,_\S_`,S_
M,\S_9LS_F<S_S,S___\``/\`,_\`9O\`F?\`S/\`__\S`/\S,_\S9O\SF?\S
MS/\S__]F`/]F,_]F9O]FF?]FS/]F__^9`/^9,_^99O^9F?^9S/^9___,`/_,
M,__,9O_,F?_,S/_,____`/__,___9O__F?__S/___P``````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````"P`````SP`B```(_P"O"1Q(L*#!@P@3*ES(L*%#
MAZQ6`)AHY:'%BQ@S-K2R8@4KC2!#BF0HL>*UB``^CES)TB(K*Q-76('9LJ;-
MAA)5#LQYLV=-E!X)!O5)U&9'A$>+OC19M"%*ICM7-)TZ$J9.@P"4`J!)56%)
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M$6<#=99B0@TN=U*0W;7868W'T59A5T-VM16"&M;$7DQ0+<D?0D`Y:%:`'Y7$
MRF\Q4D8E8$9BQZ18*&T)8(DK0:F><ZA5)!J"*JV9&VH"+CACCWHFF=Q39"+I
MV'KI]4;;=M01JM.95K:)T8//;15A<W)5ZI5QA3X:YTW5:9K88;5]!.5<T`5@
M9=6CJ5T3X:$G$2JFJKQ&=1""<?G89W<%0=<J@3#VI>1'5_;J[#5?!MCEH-/:
MQ!&P5ZWU[+:]INH@M^"&RZ"XY#[+:;GH"M=LNNS:I6V[\-Z&9[STDI54O?C6
(-6*^MP4$`#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>f19772def1977202.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f19772def1977202.gif
M1TE&.#EA5P+[`,0``$!`0("`@+^_OW]_?S\_/^_O[_#P\-_?W^#@X,_/SZ"@
MH-#0T(^/C["PL)^?GV!@8#`P,*^OKY"0D'!P<%]?7Q`0$%!04$]/3V]O;R`@
M("\O+P\/#Q\?'\#`P````/___R'Y!```````+`````!7`OL```7_X">.9&F>
M:*JN;.N^<"S/=&W?>*[O?.__P*!P2"P:C\BD<LEL.I_0J'1*K5JOV*QVRV4U
M,I[)*-`(+$0+<B#E:;O?\+A\3J_;[_B\?L_O^_^`@8*#A(6&AXB)BHEK3`@2
M'P@9"A\*E!\`(IF5ER8>#`*AHJ.DI::GJ*FJJZRMKJ^PL;*SJPP>';BYNKN\
MO;Z_P,'"P\3%QL?(R<K+S,W-$(U+'6-K`&<?%K@6:)N>`EW@X40"'N+FY^A%
M`-%.$]/E(@'RT?#>Z??X+^3Y_/W^*>N@&-CVH=X\>B@\?/O'$-^^AA`CB@OX
M1((!$0;GC:A70J'$CUT>@AQ)$@K%)A9'_P!`(.(!K@<B$'3KN+"DS2@B;^K<
M">3D$@42<%FTI*DHIX0U>2HUDG.ITZ<P?"99`*`J`$@?U%Q+4X9-4JA@=S0-
M2[:L5'0>RZJU,7:M6YYGSZ5]2[=%V[IX/\8U-Q=&@E,'\MJ\*[BPO[WB^KX@
M,&?`#08H'!"H4<#!@`@"&`06L2&!C@,8(#.XT(*!AA,.'`BP',%(@@TZ"!N>
M?0]Q.,4N"#@NH=M&@0T.$OKV6(!#ZP^>=PQP7&#SB@(</Q0@`%F$92*;D^.0
M3;O[1';I<+?HS7LW#0<7.`BWD7;`9!_+8T0?H)X$AB&@>G#WSG^+;7#BC8"*
M!N:-0``%I^0&7?]-!8`R`#RJ4>"8`YAA0%H"#$1`@3T?4+"A``0L-,!J]Q6`
M06@<#.``!1P4\`%F#+P7P8P$%C``:2_2Z&*&EV%4`@?WF8"A`!0DT*"$G5&`
M`8O!?3"B`_<1Z0`'#&"HX0<'4'G`E"+8*("*'PA@'(O.I;!??VA:\5\7`899
M1X$B,#:'=F8&1\%['2973FK2>7"`9[^U=H%G(78$"@47N/A!H7QV"-D`)7K@
M8F@';/B!!@X<@&-\(&)I:9$)D-9I01W!&:<(!\`F)I:+MO;:!XU2`!D!#A10
MP*"+?E,HJ1UNQH%G?GZ`@:DFG)GFL5&LR46;*I!'@K,R7`!CL!_`YN/_!:"$
MHN@%.&+I@`9?$7?!:;E^<,%"$4P6'Z_+,8!@*`<PL!NGD\EK0@3N^4C"!J8F
M@">XHY9[J0#GBI"NP-Z"*S`\U@KK&#SKJF`LLA0SH>P6S*8`;9S$MA#O"!=8
M6D\YU(W@8@0;*,KGKALM1(ZNNA[7Z;H0+]>MC?,Z-G.075)0P*C1C5LLN;D&
MO"L!_LH\V:XKPZROI"+$5S,+$U=L]1$7:Y$Q"@>60B`-&#CG`-28^LA`B\@)
M\%N3KR*,T4(.I%PN`T%&\.AN-2?@`:`4UD=OF'+_92_0);Q,0FMR+QHFGKN>
M1K?!LRYD;:&[PB.M"!@`&W7')%1]]>="9)W%_]8GR!D'YQ)O4),M/D<`Y(,1
M%*`!![UAP$$H87.`K084;-:@!T\6FD"*MB)M8G/<'A"!!Q%H>D&E&Q"`(P&Z
M47\`?9Y1$/V$_-)'(?,E1$"@`/@&MN*+M6+/,?K2&8]!`<,/X*+NIO6.Z(S@
M^PN_SLP[KZB9T0&=`),@.BR0S@D_8Y4($E`F$L!/.@UL00+HI((_D8"!$42.
M<XR$G!7\Y7_245OI,`/""9[@@<U9X`D$D$&[!'"`,"1"`:]PP!CB@&4X>:$-
M=]B#&5JAACR<0:@T,P7/!?&(+?!A%8"(1(?HL(E0C`IXT/*5*$+$B%;,HA*I
MP,0LB@.+7H3B%J?0Q?\PAN2)9DPC)J:8!`7`1`02L,I*-%&5!B!%C0PAAQSW
MR,<^^O&/@`RD(`=)R$(:\I"(3*0B%\G(1CIRCQ5@XQ$0T(!NN`,7$!"!`AJ`
M"Z_@\1_D.(@H1TG*4IKRE*A,I2I7R<I6NO*5L(RE+&=)RUJ*,@.2/$('-G$1
M-+SQ*BSQY"?[`<9AQG",.=BE"29@1P0\``R=X)`QG3C-3R(3!\HL029)(`$/
M7$.:U41',</YN6O>()LC<*8)'B#),I(SA^\THSEM@$XXVK$$`<`*..,)CG'R
M$UGSK$$]/[#-$DP@F/N40<3^.0XT,O28N2S"([*13H)D!0*<_&9"84".O=G_
M(`$]6J"*0)B"(\7`2^Z*`<&JB)P!5$=`8"KI`"QU4@&`-*0@K=7A*!33+AU'
M+`Y]Z``#V@1W2H=V!"`:V#R*.9)*#$\NH,!QNM5"$RCL!!CHBP:@IH*#5=`$
M#<*<4M]'@@.0"Z0E2,!/<^!/H?*'J$PP*@8V<(!4H8X%,Z5KU#@*U?%4YR\M
MS0U+G70@`5$@J`%#0;=&X+.H015.8E+42T<0-J"ZM8EP74*;#D"]SGJ6>AYH
MDBT^^]FJ1DUV&G#1;JQD*1YY)@&JN<!DO-0[;WVIKV-[Z:V*!*L9-1:V(()9
M`2B@TQ&,B%H8>`AMZSHL;G5*0YZ!T61>]C_.&O>Q_R;@@`9:2"3+7O:(F55"
MFW"VG/(N)ZN+9<RPS%M>IY;`,:G:T&YP5:C3))!<G6+`W1:EJ`!F=;N;\Y1U
M2/,>!@0G1)@Q@6,XL*'K/42_3G+,3+$$H@:YJ%(B*%MTKN-8$O2+`Y]`07W8
M&M3O6BV\22CC7$&8*I[%8#?DB-B6%&8]Y+QG5`6(P`4&X*^-K)`#<HN/O?K4
MXV>53<&P\M/[1)+C'4=8!&(BFKM$$9CYF"=?QCUA5HE58A>TU<2&03$2NKB\
MM8K`%H-=@7G&1JZF26>NF+GQ9!)PG^4$+#J^V\!^(=4RI2YJ`(GSL`A>YZ8%
MUEG",*;>O&[&*^->&;ME-?]NPTC091>"F8=B/@(3?],]]@(:;2\FP6$Y$Z=O
M!"=&T`E,IPJVG`-P-3HT+5E\$D"N6_WF&Y7)E6E(NAM;J-IRWXC/NBK,@>#H
MC6^-AC+/VG;F$01F`)L1@+6<,QWO7AJB_&"B9$C[63.S@-8,^!^YZ,<[LS:H
M-?29Z:\H0*`[$2E%#RJ!!B!#:Q=]"S+$=9)GQG8@^*4H2QK0#KAM=9]*A9C=
M,Z55\FST*UN$6WO2&W3FGF6?<WTI.6=[$8`OT"3@0,[:UQYJ1`&49@1V"5#1
M=LZ?;`5E%6HPV1"TZ06=G10+;L?E*[`Y!$N0'YI3,#`NTI:S&>M>&GPYY'7)
MM!'_C)H8B80;!PZ@X`V.CO2W*+T(3.]"97#($-.V@.4\H'K5UW)U(F1]["!'
M>\7*/H2SJWT[E7Y[8=@N!+?+O09BO_M3Z!X$N^M=!GG_NU+X#@2_"UX?<3^\
M6PC_`\,KGFJ)?[Q91LZFDDL^[)&_/%@8[P/':WZ%F?^\4SA/`C>6OBH$X4HN
M/2_ZSGG@D;"/O>QG3_O:V_[VN)=C))U`R9E<,IB;(,H)6-]Z*'O`ELA/OO*7
MS_SF.__YT#\(+I^`3C?>\P,=2/U,*&WY%7R)QT\HN@\4)?62ZJ#\6`A\\2-"
M^A%4'P`>@,!%Y.'CX7<?!;3VP.P\0`#Q>_`"RX8M_F<R_UCF`J!!`&4"(F05
M&=;2&=_V-0*B&Z&@8R_@@&>T?H+1?B(P4`@``=M`?_JR42Q0'``&.'T%`P_2
M)$["5RKE`30E+!F3>`OU9R.@@DUP?RV(@7FA@=BW?9%0#B`(<RTS`PP0:&Z"
M?GB%9GN%*DG!0B9#/N_Q,R`D<X6C/8IR/7-!A5#F:EWR/R;$A(Y6'B9#<^('
M=D%776&"*BHG0JQ25]9Q5S.@?CKX#SPX4")0`=CW1C)Q1RA`7I[&8%:E&YXF
M/VK6(7JU&ZDA.R[B,_E!(1TR9_=1,)GQ(M$1"BG25!Z!(>;B&&@U-F%R.U@B
M/TL"*[626D_V+#"V$&$S'?+C9/_+\XG!EB)S=0"[-1K4`6C/]B<I0P[RHCK#
MQ5N8-X=)1WE#8(<((`:8H$G1Q'TIX"_<1@`;X&)Q@E2DY77,H0&I-2^!42AH
MXQGX-1DS\F1$4XE?DC(F4A#?("V9`1O/HR^%THY;XB3;&&QPTC4"D%P?8&`!
M1C.EMCB8<VCZLARA$@KSQBZ(Y@-R*(S\H($3-0T&$$D=<'VJ)TPQ8#LE`!TV
MB(*HL@%.9C#?\@UPYH\B23X[=F>%HS9Z1D0>$1TCTX\!%`$?>8H&8AZ$(B('
MR2N%,BHS@S>;,X-3,X,DII!61XP8@X,EX&HT)3N@IE`CH#?6,G&%DF/\(@#?
M^")W0Y7_]2<@L1@D'K$!Q]$<K^:2OB,L-2F3Z].4!'`<PL:3Y:*3\L66[4(T
MFO-D0`EW0KEX1*DU1ED"8R.+0(:$>$4"GE@0+J(PD$&!JO,B2],:PP(=@$*.
M6)(6'L%NM@(93@8=_8@HMO(PA4F/8KA`=(,CP^(DD>(B.5E@P<&/$>9JP1$*
M!AEA`PAXH7>7>I&7H[.71WDG!+"`0B2`C"4"X^(NSR,MX.<Z`(@T1>A2X!(W
MLL(1H%%9P=$@NVDK%\!_KY549Q,!0U0\+N@BP8DH]UA9"U22)$F+!)`B3I8E
MTI*6VRDF,((E)Z(\:?F<6P)D.C.?)_(SQ:8?LTF;[&>;!H2;_^$!#G79.2=8
M!0GIG^?`@SE`?$M$H'>56%>0H`KZ'=DFH.90&2/"!2#U='UH&1AZ!!1:H>#`
MH#C@H*TWHB3*!29Z`R@J>BJZHEK0HNP1HA4:HS**!31:`R_Z>3B:HVH"H#1D
MHPKZHT!*!3M*`SVJ>49ZI%*0I#.PI)?7I$YJ$D+Z0T3JGU1:I4X`I3(@I9*W
MI5QJ,>"Q`+G02\<(``=E`LNH65E*FV(ZIDH@%=V4`2FA`&]0`1J5C$^P"'[Z
MIX`:J(+J!W)J$U*A`/(G`@_9!M#P`-OG@^(5%,XPJ91:J99ZJ9B:J;E0J"4A
M%0_02Q\P`6V0`;T4``C%ITYP"YRZJO]+(171@`!NT`F=I!(W\`BG]ZG4$`#3
M,'SL%'V^^JO`&JS".JS$6JS&>JS(ZJO31P+(^`$/,*JEMZM&00,($`#=8`G9
MMPD=,`'R`*H=`0&Y%Z[B.J[D6J[F>J[HFJ[JNJ[BNGO<Y!(!X`;79P`%-:TT
M4'V*"@\/L*>>(*VL^J^="A[T^@9OA'W@6@*0"@-V^`$9$`E@D`'\NA'^"K!R
M>GTC<18&$$<6<`D(8`%6<:H)^P)V*'R18`$5<*J4-K$46Z4!<+(!&P,3&[(N
M,%`&,$57D1`JN[)`N@!M(+-T:)L-@(<DX+,L,%!L%(0=D;,Z*Z,0$"(>H$^U
M:0(#X0'N^@'_4QL=1+L"]902'V"Q$Q"Q!:&T2UNA`7"(+@L29P%_;K`&'5`!
M;H"P-E"M&;"KS^H&CS`!!A"1;""V8RN4"!"1(99A68L/4L&S>2JJ;5`!4(NJ
M/Y"W?!NV?3N'N%`&`3`!50$!<`!5>K.X#7&H<]2U;MNS*,NX<?6XD8MT9MH!
M$B`/5A$'5C$/N+``$Z!7'N9-44L"ILI-;=`(*#NX=6>ZIQM/CJL`\N"H`!"Z
M;I`!5=&KG-0!WFH"'1"X\E:OG0L>X-$!$/!-S6JOI1N\\90+\F"Y`("Y>8IZ
M\B"IH_L"!@`&=7"E7>"JW#H/#]"KE2NTM-JGP.N],?2WJBL/'JNV_V\`KFHJ
M#YO*`ZFK`):+N:5@"QT`M@MIO7<`M_BKOS'DN)1KO.R;O,LK#PJ`"\];`X[;
M`?)[N7)`PKS6L+<[!A$\M%"@JA2,)JD[#R0,!Z^;3[&;3+A`O)5K%<CK!@)L
M`;"+"RC[D`52'`7[G_BT#J9DO]RK6?G[PDK!OSK\OST<?U41O\U;J^#KOS-<
MOE?,P04L`]U$B%19`1_,$*YZQB.PO:3KQ%#L%),;OE61P8F[P0'0P1V0OC,K
M%')<%7(@P/1[ID`0O26,M@#ZO+[;=T_\QBS@P$N0NJMKK7Y,PU41Q(Z<`JE+
MN0'POW0\JC5\QS?<!-%;"A20R`L*H&QLRO^-M\B,G`(!0*I',+S%6Q55K+P#
M3`8>#`,A',G&"\!O8!6]*JG.NP71JV"J;*$S:P%8V\*LW,HF8+A'C$VXT,?D
MZP858+XVG,<O<,`R/,=Q8,M`+`_->\G@4,SO=<SAL"8&@*AOR\(3[,PT0*]I
MZ0$6NP+\&\G_&P<"',3`&\(C/+XE_,79W,SF8*;$^ZS&;,@J<(Q5+,&I2M#P
M'*IZ=0%FK*AQ'``8#`>VW*MXK,;NE\-]?+SZC,VZ*L0WD;>42\O6#-`)G<(E
MH`"^[`$;^ZC,;!-Z/$W\RPOA&[B_4<6O!P#A+*D.G-/S\+_5O-("C<<0W0]\
M[+%T#*[<VL'?9,[_'H;.)0H>U=K#&0#$FN301;747)#3#P`!N4#.A9&Z.DU*
MO;Q'?``!F`M5Y'!)*)`+D2R^,<VH=ES2PPP6!KW#1ZV\0"RI1:L0I%#*"LU-
MR`L`E"#"*&#5.^#"$1&OA6P3OJ#)HO2_>W34>"#`>Q3.H]2\N^#`LTM2&!!)
M7`P`G>P!MJS$H-S`;N&XK"O2=:S$G.316CL'CLVB;`33`'!/C'T"N=V@8+T%
M`7""`Q#</>`+.CQ*?I3:=N!']"O)E4Q*2FW9J637@Y3:WE8</QW,@HP7?.RH
M3SW`4DTQB%&M:DJ\&^C5W2L1Q=W2NNP+D2Q*V*U[@_H&JRW;BG!(K23,_T%K
M!YR[%G]+O.*+WT"=S=BV`@U@`1"@``80S;EMJR/0``W`M1E+X6P0W<G*?`!@
MW+BTUG)TWR*NP844OQL^#P5N<:$P-H!]XBY^$"K]Q[?\XC3^?,O*`C4+!NP=
M`^CM?FLP$")@`?.GM%;,KK>7`<:=!_EMY$S>Y'X,G1NPY$XNKG;`V5-^Y>I:
MM2U`KSL.L]U`49BP`%2Q@1:5M!_Q`,9=`9RDR48=T``0R"8-10J`O+@Z$@.^
MP[[<XH+]3@74N^?4#?:;3ZL[`DR<LA(1O4G.QB>0R47=Q;^<U[EPTVEBIK:-
M#K`MR<A[S;2]UVZE+!T+Q#'[YUEY$%EIYA"QOO\>`&_F)2?#C087O<F.[@;`
MS,^2_G;AC=H!3-ZN/799,^?+3$_=D!%!J$.0S1!I`.)6`<1M&@2,?MJ:W;.0
M'N</=><%KL&!/:N")SI4W<1>/@*)&JH4CHQ</GRM7C'-#NL`[;K1KLU0=.DQ
M#NWBS.F?5T#4F]OH1`::8``&L`E=0>X/=>YMKNYO3NMH<NOCS4[E?9<%!!Z.
M+;>[^N#K?`F6`/$XJW8`'^O0/O`$+.U1W`$$/LF>',[8+J.NN@(,[P/L'A-\
M6^R2=_'I3LD:K]>U;L!^I.CQ+<*8_NCQ/O,K"K_`4.\UK:`N_^P_'?.1GDS`
MPUX$,+@&G^L(O^M+ZZK_*WR_#[VJ0^_F<)[R<QU`QUT"U`[RJGW@)?W&4F\'
M79YBY2ZC5R_P@=Q-"H9+[_[3.Q_1*F&]4A[B9S]F:?^O:\_UU_ST9@W/KBKI
M$![T=#^S7(_<+RP5M>[G[WSX+;#M4:/X%.SI%@#J>:]I>^^]DN\DE*^_O>ZV
MF;]TFQ^\A.RZD/\"VO[K59_Z..X+@9_Z]#[Z6%?ZKG_["`N@)__XN-_[.U#R
M*K#[K>_[Q(\#/O\+0,_[Q;_\,E#V=4#[9F?[S'_XSD\'T-]VTC_]$>VJ=]^Z
MU_^[VA_^+C#X*E#XRB_^Z)_[7F_/WZ_(Z?_^)G#>.BRVGY_3>UW6"2',FKK_
M__P/`ITXDJ5YHJFZLJW[PK$\T[5]X[F^\R\4?(+"C\'B.1XKDJ$0P'Q"HT$+
MH%HQ?!"0*B**_(+#XC&Y;#ZCT^HUN^U^P^/R.;UNO^/S^KT'R$14C#T\.4D9
M0ADL!!D4^AEZ=!Q*3E)66EYB9FIN<G9Z?H*&BHZ2EIJ>7@(X-B5552$U,!6.
M*BPA>%0\8'E%HOK^`@<+#Q,7&Q\C)P>I,G54!'0U`T#(EEI$(RAD0.P^02J#
MAXN/DY>;GZ-',0]-]$99='_,BE(/&60H\*;O\_?[_P,,*&R=D`F'&KB31ZK!
M$B8!5@WY)G`BQ8H6+V),1C"(04,BALP#]2#:D`"QH/](S*AR)<N6+E=N_-#.
M$#R0I.I]:!#+`,2("5\"#2IT*-%?,9U!>])A6C51"$Y^6&!2D9241:]BS:IU
MJ[R>`%JY@M4TF56N9L^B3<LO9I9`8@:-1596+=VZ=N^>8IO%R!<E4$(:FXMW
M,.'"AO_V%)+MX4^;R@0?CBQY,E>]018H"""!ZE]PD"F##BU:I5X$7[]D:*SP
ML>K1KE_#WL?6@-LP^>(>^QQ[-^_>P]@^`#LM2;S59%O[3JY\^:>8!CQ8X+Q(
MP3/<@9$SSZY]NSJ(#3I"61`2<#'=W,^C5QXS0'$F.)=YQIY^/GW7ZP^-CU]_
M/__7Z[>X$N`KUI4G7W\'(JC_UGIG$$B,>0E"&"%6"YK1X#`/2IBAABVM%X`*
M&5@H#(8;DECB1#'=)D6*0:R8FX$FPABC;(D)-**,-^*HC&7(("`"5#J1Y(T$
M/1!9I)%'(IFDDDLRV:233T*IPP_E3%"%'Q,H,I(7?'#9I9=?@AFFF&.26::9
M9[9!XS'9#&%:$!W`Y<V+.=)9YT!J&A,<!"<IT-$]^M@9J*#%['@,G![D\Y`0
M'@`ZJ*./FE(H,A*`J&@0C*(T)Z2;<HH?GF1]D)D0(&;:J:FG6B(I,M2X^0&<
MC:(:JZP@?3H,3U@H0!66'VA9ZJR_RJKJ,!(,&0^056D*K+(X"LN/C<M""V.S
M^SP;_ZVU&DZ;3K77<IM@MNALVZVX^WU[3KCCHHM>N>:<FZZ[V:U;3KOOTNM;
MO.3,6Z^^L-T[3K[[`AQ:O^+\&[#!D0T<3L$',SQ8POHU'+&]M?:SL,07G_4P
M:QAS;!_%SB;;L<AI:7S<R"<C_#&U(:/<\E4ER\6RRS,'!3,H'00I1'N7RDRS
MSRS9W(EI7]WVW!&MH9FTTDLSW;333T,=-1PJ`].0,T%(L'-$0T;9M==?@QVV
MV&.373;84X[#&:/W6-`B$Q;_'#=`07^"P"`&*!!<G'+*W?>$5`LS09`+5`#5
MVSW[G?@_='?2@'0<T0BWXI.+P_@F"YP49`!N\TRYYS`![O^+>`^9A$`T$V@M
M^>>K$V-Y)A*0#H0"%B"D]0>JLYZ[4:&SB[CNO[?.N[R^`U_\[AGA;KSRG;@>
M3/++0X])\\`\'[WUDTS_2_77<]\=\L1W'WXEV?NRO?CBDX^*^>=WG_XIZ[-_
MO?NFP!]_]/.74K_]R^-/BO[[&Z]_H_@?`($G0%$0L("Z.V`H$JA`UC$0%`Y\
MX.<B^(D)4I!R%I1$CQX!O@RB3WC"4(`"#*"+*&1`:BI<(0M;Z,(7PG!I(@0&
M(X+0`!KUR&Q&>@`$=.C#'Z*`AT`<XA`E``DBZF!(^V@`7+2@E@"09U-0E%4'
M,"4A2]WNB5&$U!1C544-8=&*9^G_(JK(>*HO9@AV0JB`%F5E1E.A44(+L,!E
MZ)@6!#RN4WB4E0$^F)R:>`B$@A2*`22@DT$B,I&*7"0C&YD,!#2$10`XX66L
M9K@A13)4D<!D,SA'GUPIY@$`,!SJ"GG((6RF1*`,@MU&R0X#F!(J'2#=S!!`
M1A)V@`I"V%Q4+."(0,ZR";:,1#`7@;;^="`UBV@'==P!(D"Z@W!^3$XR>V$`
M9E;`F1^`)N1,0K.E"*%H5N1&$+#(QB"<TP#4..<'V"F!"<R0-P#H10-V`4\;
M8JD0N=SE/$O4SYS8TP_?$<^;Z#A+VXD,G$\@%0+L^`%+$709BJA%1.6AB`Y(
M)9Z[^6=)_V[S@`6H$9TL8L0TD\/177H4I(Y@8P".`!Z7*70(),1:BBP5TWY>
MXZ8=P-M#-1J;D\(G"-0(8U0B`50)'7460W6$%:GS4I3%=!&.(&<Y_:!3=;IJ
M%O/T`Q;[`]15?J>GBRKD,DIJKY^`U2!$%<+59A;5ARK&H6(E`DZX40NZ"H$;
MKLA`!IY:GY,Z3@@?S8F?("`>*T#`DP@"+&<&&U:\1N2;\\B:#8E5$D<```LU
MC,XR-#N/KO*'HYA[TY^(4(@;@L2LO1'M279*JAKF9!5%J&4`E,FK+YB&)'/D
M;%0,LBM2]58FT@%M?9*9%,(AX0&O8E$)*5E6$AFW"\@]@G+C1"5"$\)RGME`
@J,_DTT?-2N>[=3)=FU3+'_(J)IHX<R1[V^M>E(4``#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>f19772def1977203.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f19772def1977203.gif
M1TE&.#EA-0`_`,00`!`0$$!`0*"@H&!@8/#P\"`@(#`P,.#@X'!P<-#0T+"P
ML%!04)"0D("`@,#`P````/___P``````````````````````````````````
M`````````````````````````"'Y!`$``!``+``````U`#\```7_8"..AR@0
M4*JFA](@01PCC9"L>)X_?._TC\9*,2@`CT#`0J!KJI`_X(#0,"*O1P#BX-P=
MHT"!%4L&-E#=%!198)3?O8(C#5DC%?#\@Y&V?X$&#0X"#@PB#@HN!F4#77Y`
M40,."(M8!@@*"`!8C4V//@,"`7H/`42<GG]0"*12`IM(3%Z05V"M/`6O5S<X
MGSRV/9<C#:-7`+I'!K,^M4<-7#E4L$G(9KVJV`:\3@>5@&Y9T&K8M`\&:&D$
MWCT("TB=X^5_!>AT!&,]"M,]XKX//W/HK`!FK@$2(?&800D@,$<Q(`SV/0#P
MA)P/<0U3$`S`ZHB"A+]J9<R!CP>>(YW\_WT<N6+`P9(4ZSB3&(3E"@%(%K@[
M@J(DL8,V51`,!`7"0QX!7!YA&!0"P0<XOT`P2`U)S*!/"0HY&>;*2IM9@4(H
M.4"IE*9AG:7HV!4)QH:"FJF%<.#=41X+6!(`D-9:"K/YKLAJ.*IO#X1TD1`M
M*E"I81Z((0"&?)<'GRX''CZNJ6)OK'5Q3N0XH$F>:<@XP"5Q`!I(4A$!2H;T
M%3G%3FJ526VN#>'>%1$TWP!@L%M'@N`!!$PF`Z"!`CER_>8XCB6Y@`7!E0@0
M-=LB9^/!>0`8P$`!(0>#%##`WM8[[Q7=;F&IIE"Z$ZKR@2Q8KE5@@MRM."!1
M?PTYL%P>!9P15?]]A^EU77B`(+`-!/\QB%I3!Q0RC`D!-9'A&>B%Z,!;395H
MXHDHIJCBBBRVZ.*+:0S6F8@3:B0B>BLD<".)&>I05X<I$.!2<P8<LP(X-(RR
M0@$)*B7C6DR-54`*!L$C5"F];0(D#[W=LR0*HT39V2:\%,!4)6_]P!0K>54$
M`0(.3/A15#5"H$LG!]R0R2BUJ4DEEA6Y`V20FR"@@P$GU;/``3A=I1&@!HG)
M0S>#OCD1"A,FT(@1E]$52`.;R.BG9-_)Y)2.@R7`@RS*J%!6`^Y,2:4LK,B:
M`A[*''?."CR@0*D*BS#%0)3J!+FJ&@4DD(`5G2R+U"7U5&)`,6A$92804BH8
/86A'`-0)X[?@AMM4"``[
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>f19772dedownarrow.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f19772dedownarrow.gif
M1TE&.#EA.@`=`/<``````(````"``("`````@(``@`"`@,#`P,#<P*;*\`0$
M!`@("`P,#!$1$186%AP<'"(B(BDI*55554U-34)"0CDY.?]\@/]04-8`D\SL
M_^_6QN?GUJVID#,``&8``)D``,P````S`#,S`&8S`)DS`,PS`/\S``!F`#-F
M`&9F`)EF`,QF`/]F``"9`#.9`&:9`)F9`,R9`/^9``#,`#/,`&;,`)G,`,S,
M`/_,`&;_`)G_`,S_````,S,`,V8`,YD`,\P`,_\`,P`S,S,S,V8S,YDS,\PS
M,_\S,P!F,S-F,V9F,YEF,\QF,_]F,P"9,S.9,V:9,YF9,\R9,_^9,P#,,S/,
M,V;,,YG,,\S,,__,,S/_,V;_,YG_,\S_,___,P``9C,`9F8`9ID`9LP`9O\`
M9@`S9C,S9F8S9IDS9LPS9O\S9@!F9C-F9F9F9IEF9LQF9@"99C.99F:99IF9
M9LR99O^99@#,9C/,9IG,9LS,9O_,9@#_9C/_9IG_9LS_9O\`S,P`_P"9F9DS
MF9D`F<P`F0``F3,SF68`F<PSF?\`F0!FF3-FF68SF9EFF<QFF?\SF3.9F6:9
MF9F9F<R9F?^9F0#,F3/,F6;,9IG,F<S,F?_,F0#_F3/_F6;,F9G_F<S_F?__
MF0``S#,`F68`S)D`S,P`S``SF3,SS&8SS)DSS,PSS/\SS`!FS#-FS&9FF9EF
MS,QFS/]FF0"9S#.9S&:9S)F9S,R9S/^9S`#,S#/,S&;,S)G,S,S,S/_,S`#_
MS#/_S&;_F9G_S,S_S/__S#,`S&8`_YD`_P`SS#,S_V8S_YDS_\PS__\S_P!F
M_S-F_V9FS)EF_\QF__]FS`"9_S.9_V:9_YF9_\R9__^9_P#,_S/,_V;,_YG,
M_\S,___,_S/__V;_S)G__\S___]F9F;_9O__9F9F__]F_V;__Z4`(5]?7W=W
M=X:&AI:6ELO+R[*RLM?7U]W=W>/CX^KJZO'Q\?CX^/_[\*"@I("`@/\```#_
M`/__````__\`_P#______RP`````.@`=```(C`#_"1Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@/*MC(L:/'CQXS:@1)LJ0"D08W6E2)DB!+BB];_HLID29*
MFQ!Q9M3ID&=/DRN!/BP9%.3$D#<[%O7YDZ-(I#65MH0Z5*K,F5874KTJ,"M"
CKUP';A4+-JS+K&/-II2:5NW(CVXCEHW+D"G=NWCSQ@T(`#L_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
